TW202348748A - surgical marking ink - Google Patents
surgical marking ink Download PDFInfo
- Publication number
- TW202348748A TW202348748A TW112105754A TW112105754A TW202348748A TW 202348748 A TW202348748 A TW 202348748A TW 112105754 A TW112105754 A TW 112105754A TW 112105754 A TW112105754 A TW 112105754A TW 202348748 A TW202348748 A TW 202348748A
- Authority
- TW
- Taiwan
- Prior art keywords
- ink
- water
- pen
- writing
- surgical
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000003575 carbonaceous material Substances 0.000 claims abstract description 43
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 239000002612 dispersion medium Substances 0.000 claims abstract description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 77
- 239000002245 particle Substances 0.000 claims description 55
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 54
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 25
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000003086 colorant Substances 0.000 abstract description 4
- 239000000976 ink Substances 0.000 description 255
- 239000006185 dispersion Substances 0.000 description 38
- 238000012360 testing method Methods 0.000 description 38
- 210000003491 skin Anatomy 0.000 description 24
- -1 sweat Substances 0.000 description 24
- 230000005251 gamma ray Effects 0.000 description 21
- 238000010586 diagram Methods 0.000 description 20
- 239000004615 ingredient Substances 0.000 description 17
- 210000003205 muscle Anatomy 0.000 description 17
- 230000000704 physical effect Effects 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- 241000700159 Rattus Species 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 210000002615 epidermis Anatomy 0.000 description 12
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 12
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 12
- 231100000987 absorbed dose Toxicity 0.000 description 11
- 230000036512 infertility Effects 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 230000003187 abdominal effect Effects 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 9
- 210000005178 buccal mucosa Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 210000000689 upper leg Anatomy 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000011362 coarse particle Substances 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 238000002695 general anesthesia Methods 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 230000005856 abnormality Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000009877 rendering Methods 0.000 description 5
- 210000003625 skull Anatomy 0.000 description 5
- 210000002105 tongue Anatomy 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 210000003038 endothelium Anatomy 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 229940120904 succinylcholine chloride Drugs 0.000 description 3
- YOEWQQVKRJEPAE-UHFFFAOYSA-L succinylcholine chloride (anhydrous) Chemical compound [Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C YOEWQQVKRJEPAE-UHFFFAOYSA-L 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920005749 polyurethane resin Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000003918 potentiometric titration Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- YJUUZFWMKJBVFJ-UHFFFAOYSA-N 1,3-dimethylimidazolidin-4-one Chemical compound CN1CN(C)C(=O)C1 YJUUZFWMKJBVFJ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- COBPKKZHLDDMTB-UHFFFAOYSA-N 2-[2-(2-butoxyethoxy)ethoxy]ethanol Chemical compound CCCCOCCOCCOCCO COBPKKZHLDDMTB-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000032400 Retinal pigmentation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011981 development test Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- NVVZQXQBYZPMLJ-UHFFFAOYSA-N formaldehyde;naphthalene-1-sulfonic acid Chemical compound O=C.C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 NVVZQXQBYZPMLJ-UHFFFAOYSA-N 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 229950008532 methylrosanilinium chloride Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HXHCOXPZCUFAJI-UHFFFAOYSA-N prop-2-enoic acid;styrene Chemical compound OC(=O)C=C.C=CC1=CC=CC=C1 HXHCOXPZCUFAJI-UHFFFAOYSA-N 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- YFNKIDBQEZZDLK-UHFFFAOYSA-N triglyme Chemical compound COCCOCCOCCOC YFNKIDBQEZZDLK-UHFFFAOYSA-N 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/16—Writing inks
- C09D11/17—Writing inks characterised by colouring agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Abstract
Description
本發明係有關於用於在手術等之醫療行為中於皮膚表皮或經切開的皮膚組織、器官、肌肉、口腔內、舌頭、骨骼等之表面或內面、剖面等實施手術用標記(surgical marking)可較佳使用之手術用之墨水(手術墨水)。The present invention relates to surgical markings for performing surgical markings on the surface of the skin or on the surface or inner surface or cross section of incised skin tissue, organs, muscles, oral cavity, tongue, bones, etc. during medical procedures such as surgery. ) is a surgical ink (surgical ink) that can be better used.
手術尤其是外科手術中,為了進行病變部分、切除部位、血管及神經等之位置確認,以及於醫生及護理師間之資訊傳遞及手術順序之記錄及確認等,一般進行於皮膚表皮及肌肉、骨骼、器官等之活體上以手術墨水實施線或點、數字、文字之標記。作為其方法,有使用於前端浸漬有墨水之竹串或筆標記對象部位之方法,或使用填充有墨水之筆狀手術用書寫工具(手術筆)書寫之方法,以注射器等將墨水注入對象部位之方法等,作為用於此之墨水及器具於例如專利文獻1、專利文獻2、專利文獻3、專利文獻4、專利文獻5等中已有揭示。In surgery, especially surgical operations, in order to confirm the location of the diseased part, resection site, blood vessels and nerves, etc., as well as to transmit information between doctors and nurses and record and confirm the surgical sequence, it is generally performed on the skin epidermis and muscles, Marking of lines, dots, numbers, and characters with surgical ink on living bodies such as bones and organs. Methods include marking the target site using a bamboo skewer or pen with the tip impregnated with ink, writing using a pen-like surgical writing instrument (surgical pen) filled with ink, and injecting the ink into the target site with a syringe or the like. Methods, etc., and inks and instruments used therefor are disclosed in, for example, Patent Document 1, Patent Document 2, Patent Document 3, Patent Document 4, Patent Document 5, and the like.
作為手術墨水,作為主要之要求特性舉例有即使對於經血液或汗液、體液等之油分/水分覆蓋之部位亦不流動且可固定於表面之固定性、固定後可快速乾燥且不會引起摩擦或滲開之乾燥性、不會因體液或生理食鹽水等而容易溶解、變質之耐水性、實現手術所需之視認性的顯色性、即使為了消毒而照射γ射線亦不會變性之γ射線抗性、對於欲塗佈部位而調整為最適pH之低刺激性、僅以無毒/安全之材料構成之對人體不造成不良影響之活體相容性。 雖謀求有儘可能較多地滿足該等要求特性之手術墨水,但其中特別重要的是固定性、顯色性及活體相容性。且,為了用於對標記部位顯見呈現之皮膚表皮等之標記,謀求有色素不沉積且滿足容易以紗布等擦過而簡單消除著色於手術後不殘留痕跡之擦除姓。 此外,作為手術筆用墨水使用時,亦必須滿足在筆內部之細密流路中亦不堵塞而可安定噴出墨水之噴出性,及即使長期間保存墨水亦不變質、凝固、分離、沉澱而確保噴出性之長期安定性。 Examples of the main required characteristics of a surgical ink include the ability to remain fixed to the surface without flowing even to areas covered with oil/moisture content such as blood, sweat, body fluids, etc., and the ability to dry quickly after being fixed without causing friction or friction. Dryness that allows it to bleed, water resistance that does not easily dissolve or deteriorate with body fluids or physiological saline, color development that enables visibility required for surgery, and gamma rays that do not denature even when gamma rays are irradiated for disinfection. Resistance, low irritation by adjusting the pH to the optimum for the site to be applied, and in vivo compatibility that does not cause adverse effects on the human body and is made only of non-toxic/safe materials. Although we strive to have surgical inks that meet as many of these required properties as possible, fixation, color development and in vivo compatibility are particularly important. In addition, in order to be used for marking the skin epidermis where the marked area is clearly visible, it is necessary to have an erasing method that does not deposit pigment and can be easily wiped with gauze or the like to easily remove the staining without leaving traces after surgery. In addition, when used as an ink for surgical pens, it must also ensure that the fine flow path inside the pen can be ejected stably without clogging, and the ink must not deteriorate, solidify, separate, or precipitate even if it is stored for a long time. Long-term stability of ejection properties.
然而,目前並不存在有滿足該等要求特性,且可於皮膚表皮或經切開之皮膚組織、器官、肌肉、口腔內、舌頭、骨骼等之廣範圍部位的表面或內面、剖面等實施良好標記而可適合用於作為手術用墨水之高性能手術墨水。However, there is currently no device that meets these requirements and can perform well on the surface or inner surface, cross-section, etc. of a wide range of parts such as the skin epidermis or incised skin tissue, organs, muscles, oral cavity, tongue, bones, etc. It is a high-performance surgical ink suitable for use as a surgical ink.
例如,以專利文獻1、專利文獻2為代表之以往的手術墨水基於顯色性及噴出性高,而使用氯化琥珀醯膽鹼(methylrosanilinium chloride)、亞甲藍作為色材,但該等於近年來被指出有致癌性之可能性及有引起染色體異常之可能性,不確保活體相容性。 作為不使用氯化琥珀醯膽鹼及亞甲藍之手術墨水,雖揭示有使用食用色素等作為色材之手術墨水(專利文獻3),但由於所用之色材為染料,故固定性、耐水性不足,對於經血液等之體液或生理食鹽水等覆蓋之骨骼、肌肉、器官等因會滲開、溶解、流動等而無法良好地標記,於手術用途之使用中被限定於對皮膚表皮及鋪巾等之不會濡濕之對象的標記。 For example, conventional surgical inks represented by Patent Document 1 and Patent Document 2 use methylrosanilinium chloride and methylene blue as color materials because of their high color development and ejection properties. However, this is not the same as in recent years. It has been pointed out that it may be carcinogenic and may cause chromosomal abnormalities. In vivo compatibility is not guaranteed. As a surgical ink that does not use succinylcholine chloride and methylene blue, there is disclosed a surgical ink that uses food coloring as a color material (Patent Document 3). However, since the color material used is a dye, it has problems with fixation and water resistance. Insufficient in nature, bones, muscles, organs, etc. covered by body fluids such as blood or physiological saline cannot be well marked because they will leak, dissolve, flow, etc., and the use for surgical purposes is limited to the skin epidermis and Marking of items such as towels that will not get wet.
又,以專利文獻4、專利文獻5為代表之以注射器等注入到對象部位為主要使用形態之墨水,假定其滯留於活體組織中,由於不含與外界空氣接觸而形成被膜之成分,故想見會有固定性及耐水性、乾燥性不足,經塗佈之墨水會簡單流動/溶解之虞。因此,不適於對骨骼及肌肉之無法注入墨水之部位的標記。又,無法將色材之分散狀態及粒子大小調整成適合作為手術筆,且以筆使用時有引起噴出不良等之虞。此外,以注射器注入墨水之方法由於無法任意描繪細線及曲線等,因此無法書寫文字及數字等,其用途受到限制。In addition, inks represented by Patent Document 4 and Patent Document 5 are mainly used by injecting a syringe or the like into a target site. It is assumed that the ink is retained in the living tissue and does not contain components that form a film when it comes into contact with the outside air. There is a risk that the fixation, water resistance, and drying properties will be insufficient, and the coated ink will easily flow/dissolve. Therefore, it is not suitable for marking parts of bones and muscles where ink cannot be injected. In addition, the dispersion state and particle size of the color material cannot be adjusted to be suitable for use as a surgical pen, and there is a risk of causing ejection failure when used as a pen. In addition, the method of injecting ink with a syringe cannot draw thin lines and curves at will, so it is impossible to write letters, numbers, etc., and its use is limited.
用於食品等之可食用墨水等具有活體相容性,但此種墨水無法滿足作為手術墨水之要求特性,並不適用。 例如,用於食品等之可食用印刷墨水係以藉由塗覆或烘烤等之表面處理預先將表面狀態固定之被印刷體之印刷為前提而設計者,於根據部位及狀況而塗佈對象之表面狀態不一樣之手術用途中,認為無法充分發揮固定性、顯色性等之性能。特別是,以用於經乾燥之被印刷體的印刷為主要使用形態之墨水,由於因活體之覆蓋血液或用以洗淨之生理食鹽水等而將墨水溶解而流動,故認為難以於手術中實施必要的標記。且,該等可食用墨水係以於體內可消化為前提,而不用考慮被印刷體中之擦除性、耐水性及低刺激性。 化妝品用墨水雖滿足對於皮膚表皮等之活體相容性、皮膚刺激性,但對於切開的肌肉、器官、骨骼使用時,當然不被考慮,且有對身體造成不良影響之虞。又,係以洗淨時使用肥皂等藉強烈摩擦洗掉為前提,雖係設計為耐水性、固定性非常強,但由於對於手術部位無法進行此種洗淨,故認為不具有作為手術墨水之必要擦除性。 [先前技術文獻] [專利文獻] Edible inks used for food, etc. have biocompatibility, but such inks cannot meet the required characteristics as surgical inks and are not suitable. For example, edible printing ink for food, etc. is designed on the premise of printing on a printed object whose surface state has been fixed in advance through surface treatment such as coating or baking, and is applied to the object according to the location and conditions. In surgical applications with different surface conditions, it is considered that the performance of fixation, color development, etc. cannot be fully exerted. In particular, inks that are mainly used for printing on dried objects to be printed are considered to be difficult to use during surgery because the ink is dissolved and flows due to blood covering the living body or physiological saline used for cleaning. Implement necessary markup. Moreover, these edible inks are based on the premise that they can be digested in the body, without considering the erasability, water resistance and low irritation of the printed object. Although cosmetic ink meets the requirements of in vivo compatibility and skin irritation for skin epidermis, etc., it is of course not considered when used on cut muscles, organs, and bones, and may cause adverse effects on the body. In addition, it is assumed that the ink can be washed away by strong friction using soap etc. during cleaning. Although it is designed to be very water-resistant and highly fixable, it is considered that it is not suitable as a surgical ink because it cannot be washed at the surgical site. Necessary erasure. [Prior technical literature] [Patent Document]
[專利文獻1]日本專利第5888658號公報 [專利文獻2]US2019/125483 Al [專利文獻3]日本特公昭63-044788號公報 [專利文獻4]日本特開2007-262062號公報 [專利文獻5]日本專利第5099815號公報 [Patent Document 1] Japanese Patent No. 5888658 [Patent Document 2] US2019/125483 Al [Patent document 3] Japanese Patent Publication No. 63-044788 [Patent Document 4] Japanese Patent Application Publication No. 2007-262062 [Patent Document 5] Japanese Patent No. 5099815
[發明欲解決之課題][Problem to be solved by the invention]
本發明之目的係為了消除先前技術之上述問題點。亦即本發明之目的係提供僅以活體相容性之某成分構成,滿足作為手術墨水所必要之要求特性,亦適合使用作為手術筆用之墨水的新穎墨水。 [用以解決課題之手段] The purpose of the present invention is to eliminate the above-mentioned problems of the prior art. That is, the object of the present invention is to provide a novel ink that is composed only of certain components that are biocompatible, meets the required characteristics as a surgical ink, and is also suitable for use as an ink for a surgical pen. [Means used to solve problems]
因此本發明人等為了達成上述目的而進行積極檢討之結果,發現於使用碳材料,作為分散介質主要包含水的墨水中,添加特定的高分子材料,並將pH調整於特定範圍內,可獲得僅以活體相容性之某成分構成,滿足作為手術墨水、手術筆用墨水所必要之要求特性之優異墨水,因而完成本發明。此外發現藉由添加適當之特定鹼性物質或有機溶劑,或調整分散粒徑,可獲得能發揮作為手術筆用墨水之更優異性能的墨水。Therefore, the inventors of the present invention have actively examined in order to achieve the above object, and found that by using a carbon material and adding a specific polymer material to an ink mainly containing water as a dispersion medium, and adjusting the pH within a specific range, an ink can be obtained. The present invention was completed by creating an excellent ink that is composed only of a certain component that is compatible with the living body and satisfies the required characteristics as a surgical ink and surgical pen ink. In addition, it was found that by adding appropriate specific alkaline substances or organic solvents, or adjusting the dispersed particle size, an ink that can exhibit better performance as a surgical pen ink can be obtained.
亦即本發明係提供 (1) 一種手術墨水,其特徵係至少包含色材、分散介質及黏度平均分子量為1,000~220,000之水溶性高分子之墨水,前述色材係碳材料,墨水之pH為4.0~11.0,前述水溶性高分子之含量相對於色材100重量份為20~200重量份,作為前述分散介質包含構成墨水之液體的50重量%以上之水。 (1) 如(1)之墨水,其中前述碳材料為活性碳。 (3) 如前述(1)或(2)之墨水,其中於墨水液中包含5重量%至30重量%之水溶性有機溶劑。 (4) 如前述(3)之墨水,其中前述水溶性有機溶劑包含乙醇、異丙醇、聚乙二醇、丙二醇及甘油中之1種以上。 (5) 如前述(1)至(4)中任一項之墨水,其中前述碳材料之平均分散粒徑為50nm~1μm。 (6) 如前述(1)至(5)中任一項之墨水,其中墨水液中包含0.01~ 1.00重量%之碳酸鈉及氫氧化鈉中之1種以上。 (7) 如前述(1)至(6)中任一項之墨水,其係手術筆用墨水。 (8) 一種化妝品用墨水,其係由如前述(1)至(7)中任一項之墨水所成。 (9) 一種可食用墨水,其係由如前述(1)至(7)中任一項之墨水所成。 (10) 一種如前述(1)至(9)中任一項之墨水之製造方法,其特徵係對於墨水全重量添加0.01~1.00重量%之鹼性物質。 (11) 如前述(10)之製造方法,其中前述鹼性物質包含碳酸鈉及氫氧化鈉中之1種以上。 (12) 如前述(11)之製造方法,其中前述鹼性物質為氫氧化鈉。 [發明效果] That is to say, the present invention provides (1) A surgical ink, which is characterized by at least including a color material, a dispersion medium and a water-soluble polymer ink with a viscosity average molecular weight of 1,000 to 220,000. The aforementioned color material is a carbon material, and the pH of the ink is 4.0 to 11.0. The aforementioned water-soluble polymer The content of the organic polymer is 20 to 200 parts by weight based on 100 parts by weight of the color material, and the dispersion medium includes more than 50% by weight of water of the liquid constituting the ink. (1) The ink of (1), wherein the aforementioned carbon material is activated carbon. (3) The ink as described in (1) or (2) above, wherein the ink contains 5% to 30% by weight of a water-soluble organic solvent. (4) The ink as in the above (3), wherein the water-soluble organic solvent includes at least one of ethanol, isopropyl alcohol, polyethylene glycol, propylene glycol and glycerin. (5) The ink according to any one of the above (1) to (4), wherein the average dispersed particle size of the aforementioned carbon material is 50 nm~1 μm. (6) The ink according to any one of the above (1) to (5), wherein the ink liquid contains 0.01 to 1.00% by weight of at least one of sodium carbonate and sodium hydroxide. (7) The ink described in any one of the above (1) to (6) is an ink for surgical pens. (8) A cosmetic ink made of the ink according to any one of the above (1) to (7). (9) An edible ink made of the ink according to any one of the above (1) to (7). (10) A method for manufacturing ink according to any one of the above (1) to (9), characterized by adding 0.01 to 1.00% by weight of an alkaline substance based on the total weight of the ink. (11) The production method of (10) above, wherein the alkaline substance includes at least one of sodium carbonate and sodium hydroxide. (12) The production method of (11) above, wherein the alkaline substance is sodium hydroxide. [Effects of the invention]
本發明之墨水由於滿足作為手術墨水重要之要求特性,故可塗佈於皮膚表皮或經切開之皮膚組織、器官、肌肉、口腔內、舌頭、骨骼等之廣範圍部位的表面或內面、剖面等,可適合作為廣範圍手術中之手術標記用。 此外,由於亦具備作為手術筆用墨水之適宜物性,故藉由填充於筆中使用,可調節自細線至粗線的描繪線寬度,可滑順且安定地書寫任意之描繪線或文字、數字、記號等,有便利性的優點。 Since the ink of the present invention satisfies the characteristics required as an important surgical ink, it can be applied to the surface, inner surface, and cross-section of a wide range of parts such as the skin epidermis or incised skin tissue, organs, muscles, oral cavity, tongue, bones, etc. etc., and can be used as surgical markers in a wide range of surgeries. In addition, since it also has suitable physical properties as an ink for surgical pens, by filling it in the pen and using it, the width of the drawing line from thin to thick can be adjusted, and any drawing line, text, or number can be written smoothly and stably. , marks, etc., which have the advantage of convenience.
本發明之墨水之特徵係至少包含色材、分散介質及水溶性高分子,且使用碳材料作為色材。 [碳材料] 本發明之特徵在於使用碳材料。作為本發明所用之碳材料,可廣泛利用有活體相容性者,可較佳地使用活性碳及碳黑、石墨、石墨(graphite)、石墨烯、富勒烯等。該等碳材料由於視認性優異,故除了可實現手術所需之顯色性以外,亦具有活體相容性。又,由發明人等之檢討了解到藉由使用碳材料作為色材,可對墨水賦予γ射線耐性。其機制雖尚未完全清楚,但推測分散於墨水中之碳材料遮罩了γ射線而發揮防止水溶性高分子等之其他構成物的變質之作用。該作用於碳材料為活性碳且水溶性高分子為聚乙烯吡咯烷酮時尤其明顯。 該等碳材料中,特佳使用著色性、分散性特別優異且可比較便宜取得之活性碳。又,該等碳材料可單獨使用1種亦可併用2種以上。 The ink of the present invention is characterized in that it contains at least a color material, a dispersion medium and a water-soluble polymer, and uses a carbon material as the color material. [Carbon material] The present invention is characterized by the use of carbon materials. As the carbon material used in the present invention, those having biocompatibility can be widely used, and activated carbon, carbon black, graphite, graphite, graphene, fullerene, etc. can be preferably used. Since these carbon materials have excellent visibility, in addition to achieving the color rendering required for surgery, they also have in vivo compatibility. In addition, the inventors found out through examination that by using a carbon material as a color material, gamma ray resistance can be imparted to the ink. Although the mechanism is not completely clear, it is speculated that the carbon material dispersed in the ink blocks gamma rays and prevents deterioration of other components such as water-soluble polymers. This effect is particularly obvious when the carbon material is activated carbon and the water-soluble polymer is polyvinylpyrrolidone. Among these carbon materials, activated carbon, which is particularly excellent in coloring properties and dispersibility and can be obtained relatively cheaply, is preferably used. Moreover, these carbon materials may be used individually by 1 type, or may be used in combination of 2 or more types.
[活性碳] 活性碳係黑色的多孔質粉末,一般利用其細孔使用於除臭、水凈化、廢水處理、觸媒擔持等。特別是經純化之活性碳被當作藥用碳而服用,用於吸附腸內之氣體或有毒物質而排出體外。本發明中作為此等色材係使用一般不作為色材之活性碳作為黑色色材。 活性碳係作為比表面積極大之碳材料而已知。藉由將木材等碳材料加熱,可獲得備長碳等之所謂碳(該步驟稱為「碳化」),但碳(包括呈粉末者)之比表面積一般說是300~500m 2/g。相對於此,活性碳已知藉由將碳進而於1000℃附近之高溫下進行處理,使其比表面積達到800~2000m 2/g,進而為500~3000m 2/g(如此之碳材料藉由於高溫進行處理使比表面積增大而成為活性碳之步驟稱為「賦活」或「活化反應」),而成為具有極高吸附性能者。 [Activated Carbon] Activated carbon is a black porous powder that is generally used for deodorization, water purification, wastewater treatment, catalyst support, etc. by utilizing its pores. In particular, purified activated carbon is taken as medicinal carbon to absorb gases or toxic substances in the intestines and eliminate them from the body. In the present invention, activated carbon, which is generally not used as a color material, is used as the black color material. Activated carbon is known as a carbon material with a very large specific surface area. By heating carbon materials such as wood, so-called carbon such as binchotan can be obtained (this step is called "carbonization"), but the specific surface area of carbon (including powdered ones) is generally said to be 300~ 500m2 /g. On the other hand, activated carbon is known to have a specific surface area of 800 to 2000 m 2 /g and further to 500 to 3000 m 2 /g by treating the carbon at a high temperature near 1000°C (in this way, the carbon material is The step of treating it at high temperature to increase the specific surface area and turn it into activated carbon is called "activation" or "activation reaction"), and it becomes one with extremely high adsorption performance.
一般活性碳係以煤或椰子殼等之碳物質作為原料,於高溫下與氣體或化學品反應而製成。於原料中含浸氯化鋅溶液後於一定條件下加熱賦活之化學品賦活法、將原料與經加熱之水蒸氣於800~1000℃之溫度下賦活之水蒸氣賦活法雖為已知,但本發明中,活性碳之製造方法不特別要求。 活性碳根據原料而大致分為3種,即「煤系」、「植物系」及「其他」,但本發明中可不受特別限制地使用。 Generally, activated carbon is made from carbon materials such as coal or coconut shells as raw materials, which react with gases or chemicals at high temperatures. Although the chemical activation method of impregnating the raw materials with zinc chloride solution and then heating and activating it under certain conditions, and the water vapor activation method of activating the raw materials and heated water vapor at a temperature of 800~1000°C are known, this method In the invention, the manufacturing method of activated carbon is not particularly required. Activated carbon is roughly divided into three types according to raw materials, namely, "coal-based", "plant-based" and "others", but it can be used without particular restrictions in the present invention.
又,根據形狀大致分為粉末活性碳及粒狀活性碳。粉末活性碳係指具有通過100網眼(網眼開口0.15mm)之篩的粒度之粉末,粒狀活性碳係指不通過該篩之粒度者。此外,作為特殊形狀者,有纖維狀活性碳、特殊成形活性碳(蜂窩狀,板狀(薄片狀))。本發明中,基於更微細且分散性/著色性優異,較佳使用粉末活性碳。In addition, it is roughly divided into powder activated carbon and granular activated carbon according to its shape. Powdered activated carbon refers to powder with a particle size that can pass through a sieve of 100 mesh (mesh opening 0.15mm), and granular activated carbon refers to one with a particle size that does not pass the sieve. In addition, as special shapes, there are fibrous activated carbon and special shaped activated carbon (honeycomb shape, plate shape (sheet shape)). In the present invention, powdered activated carbon is preferably used because it is finer and has excellent dispersibility/colorability.
本發明所使用之活性碳之物性未特別限制,但一般係平均粒徑為1~100μm,特佳為5~70μm。比表面積亦未特別限制,但較佳為500~3000m 2/g,特佳為1000~2000m 2/g。總細孔容積亦未特別限制,但較佳為0.3~5ml/g,更佳為0.5~4ml/g,最佳為0.5~3ml/g。 The physical properties of the activated carbon used in the present invention are not particularly limited, but generally the average particle size is 1 to 100 μm, and preferably 5 to 70 μm. The specific surface area is not particularly limited, but is preferably 500 to 3000 m 2 /g, and particularly preferably 1000 to 2000 m 2 /g. The total pore volume is not particularly limited, but is preferably 0.3 to 5 ml/g, more preferably 0.5 to 4 ml/g, and most preferably 0.5 to 3 ml/g.
平均細孔直徑較佳為1~20nm,特佳為2~10nm。活性碳之pH較佳為3~8,特佳為4.5~7.5。活性碳中之鐵分較佳為0.03重量%以下,特佳為0.01重量%以下。pH、平均粒徑、比表面積、總細孔容積、平均細孔直徑、鐵份之測定係採用JIS K 1474-91之方法。The average pore diameter is preferably 1 to 20 nm, and particularly preferably 2 to 10 nm. The pH of activated carbon is preferably 3 to 8, and particularly preferably 4.5 to 7.5. The iron content in the activated carbon is preferably 0.03% by weight or less, particularly preferably 0.01% by weight or less. The pH, average particle size, specific surface area, total pore volume, average pore diameter, and iron content were measured using the method of JIS K 1474-91.
又,本發明中使用之活性碳,較佳為依據JIS K 1474-91及食品添加物公定書中記載之方法,氯化物(以Cl計)為0.53%以下,硫酸鹽(以SO 4計)為0.48%以下,鋅為0.10%以下,砷(以As 2O 3計)為4.0μg/g以下者。若為該範圍,則由於符合食品添加物標準,故對人體無毒性,且可防止雜質對墨水物性之影響。 In addition, the activated carbon used in the present invention is preferably based on the method described in JIS K 1474-91 and the official document on food additives. The chloride (calculated as Cl) is preferably 0.53% or less, and the sulfate (calculated as SO 4 ) It is 0.48% or less, zinc is 0.10% or less, and arsenic (calculated as As 2 O 3 ) is 4.0 μg/g or less. If it is within this range, it is non-toxic to the human body because it complies with food additive standards, and can prevent impurities from affecting the physical properties of the ink.
活性碳之調配量於墨水中,宜為0.1重量%至10重量%,較佳為0.5重量%至8重量%,更佳為1重量%至5重量%。未達0.1重量%時,作為著色劑之濃度較稀,且有墨水之顯色性不足之情況。超過10重量%時,因活性碳之凝集所致之經時安定性不良,進而自標記筆之噴出性降低,而變成難以安定地書寫。The blending amount of activated carbon in the ink is preferably 0.1% to 10% by weight, preferably 0.5% to 8% by weight, and more preferably 1% to 5% by weight. When the content is less than 0.1% by weight, the concentration of the colorant is relatively thin, and the color development property of the ink may be insufficient. When it exceeds 10% by weight, the stability over time is poor due to aggregation of activated carbon, and the ejection properties of the self-marking pen are further reduced, making it difficult to write stably.
[水溶性高分子] 本發明之特徵在於含有黏度平均分子量為1,000~ 220,000的水溶性高分子。一般,為了製造將顏料等之固體微粒子分散於液體介質之液狀組成物,而添加稱為分散劑之化合物。該等係具有以顏料等之固體微粒子安定地分散於分散介質中之功能的化合物,若大致區分,則大致分為比較低分子量之稱為界面活性劑之化合物與更高分子量之高分子化合物。 [Water-soluble polymer] The present invention is characterized by containing water-soluble polymers with a viscosity average molecular weight of 1,000 to 220,000. Generally, in order to produce a liquid composition in which solid fine particles such as pigments are dispersed in a liquid medium, a compound called a dispersant is added. These are compounds that have the function of stably dispersing solid particles such as pigments in a dispersion medium. If roughly distinguished, they can be roughly divided into relatively low molecular weight compounds called surfactants and higher molecular weight polymer compounds.
其中,高分子化合物一般有如下形態:於分子鏈具有較多親水基,且對其水合有水分子而溶解之形態;以長鏈胺基醯胺、丙烯酸、多羧酸及其鹽等為主要構造,作為吸附於固體微粒子之吸附基,具有醯胺或胺等之鹼性者、具有羧基及磷酸基等之酸性基而作為中和鹽之可溶性形態者。相對於該等一般固體微粒子分散方法,本發明之特徵係藉由調配高分子、水溶性且黏度平均分子量為1,000~220,000者,使固體微粒子的碳材料安定分散。不限於特別作為分散劑而已知者。Among them, polymer compounds generally have the following forms: they have many hydrophilic groups in the molecular chain, and are dissolved when hydrated with water molecules; long-chain aminoamides, acrylic acid, polycarboxylic acids and their salts are the main ones The structure is a soluble form of a neutralized salt having an alkaline form such as a amide or amine as an adsorption group adsorbed on solid microparticles, or an acidic group such as a carboxyl group or a phosphate group. Compared with these general solid microparticle dispersion methods, the characteristic of the present invention is to stably disperse the carbon material of the solid microparticles by formulating a polymer that is water-soluble and has a viscosity average molecular weight of 1,000 to 220,000. It is not limited to those specifically known as dispersants.
水溶性高分子之黏度平均分子量為1,000~220,000,較佳為2,000~100,000,更佳為5,000~ 100,000,最佳為7,000~50,000。黏度平均分子量若低於1,000,則書寫時墨水無法被膜化,無法固定於書寫對象。黏度平均分子量超過220.000時,與書寫對象之固定性變強,無法獲得作為手術墨水所需之擦除性。 黏度平均分子量之測定基本上係利用高分子論文集第38卷第7期第457-463頁(1981年7月)記載之分子量測定方法。亦即藉以下順序。 The viscosity average molecular weight of the water-soluble polymer is 1,000~220,000, preferably 2,000~100,000, more preferably 5,000~100,000, most preferably 7,000~50,000. If the viscosity average molecular weight is less than 1,000, the ink will not be filmed during writing and will not be fixed to the writing object. When the viscosity average molecular weight exceeds 220.000, the fixation to the writing object becomes stronger and the erasability required as a surgical ink cannot be obtained. The determination of viscosity average molecular weight is basically based on the molecular weight determination method described in Polymer Papers, Volume 38, Issue 7, Pages 457-463 (July 1981). That is, borrow the following order.
(1)將試料添加於過量丙酮中進行沉澱純化。該操作重複2次後,減壓乾燥直到丙酮氣味消失。 (2)製作純化後之試料的水溶液,使用烏氏黏度計(水,120秒),使用Mark-Kuhn-Houwink之式(Mark-Houwink-Sakurada之式),求出黏度平均分子量。Mark-Kuhn-Houwink之式的係數M及α係使用上述高分子論文集中記載者。但,即使為其他方法若可獲得同等結果,則亦無妨。 (1) Add the sample to excess acetone for precipitation purification. After repeating this operation twice, dry under reduced pressure until the smell of acetone disappears. (2) Prepare an aqueous solution of the purified sample, use an Ubbelohde viscometer (water, 120 seconds), and calculate the viscosity average molecular weight using the Mark-Kuhn-Houwink formula (Mark-Houwink-Sakurada formula). The coefficients M and α of the Mark-Kuhn-Houwink formula are those described in the above-mentioned collection of polymer papers. However, it does not matter if the same result can be obtained by other methods.
又,由於分子量數值有測定誤差等,故可變動約10%。因此,即使為前述數值範圍之10%左右的上下範圍亦無妨。In addition, the molecular weight value may vary by approximately 10% due to measurement errors, etc. Therefore, it does not matter if it is within a range of approximately 10% of the above numerical range.
作為本發明所用之水溶性高分子,特佳使用非離子性者。作為極性之指標有酸價,本發明中酸價較佳為30mgKOH/g以下,更佳為20mgKOH/g以下,又更佳為5mgKOH/g以下,最佳完全檢測不出酸價(酸價實質上為0mgKOH/g)。於該範圍內,碳材料之分散性能與墨水的耐水性等性能特別優異。As the water-soluble polymer used in the present invention, nonionic polymers are particularly preferably used. As an indicator of polarity, there is acid value. In the present invention, the acid value is preferably 30 mgKOH/g or less, more preferably 20 mgKOH/g or less, and more preferably 5 mgKOH/g or less. It is best that the acid value cannot be detected at all (the acid value is essentially Above is 0mgKOH/g). Within this range, the dispersion performance of the carbon material and the water resistance of the ink are particularly excellent.
酸價之測定係依據DIN53402之方法,更具體如下。 (1)稱取試料0.9~1.3g於燒杯中。 (2)加入丙酮50ml。 (3)使用0.1N NaOH水溶液以自動電位差滴定裝置測定。自動電位差滴定裝置無論使用哪種裝置結果均相同。 (4)藉由下述計算式求出胺價。 The determination of acid value is based on the method of DIN53402, more specifically as follows. (1) Weigh 0.9~1.3g of the sample into a beaker. (2) Add 50ml of acetone. (3) Measure with an automatic potentiometric titration device using a 0.1N NaOH aqueous solution. Automatic potentiometric titration device The results are the same regardless of which device is used. (4) Calculate the amine value according to the following calculation formula.
酸價=[(a-b)×5.61]/E(mgKOH/g)Acid value=[(a-b)×5.61]/E(mgKOH/g)
a:滴定所需之0.1N NaOH之ml數 b:空白滴定所需之0.1N NaOH之ml數 E:試料重量(g) (5)表示:表示至小數點第一位。 a: The number of ml of 0.1N NaOH required for titration b: The number of ml of 0.1N NaOH required for blank titration E: Sample weight (g) (5) Expression: Express to the first decimal point.
作為以上之水溶性高分子,具體舉例為酪蛋白、水溶性纖維素衍生物、聚乙烯吡咯烷酮、苯乙烯丙烯酸等之具有酸價的丙烯酸系高分子,具有羧酸基之水溶性高分子等可根據被書寫物而適當選擇。Specific examples of the above water-soluble polymers include acrylic polymers with acid values such as casein, water-soluble cellulose derivatives, polyvinylpyrrolidone, styrene acrylic acid, etc. Water-soluble polymers with carboxylic acid groups can be used. Choose appropriately according to the object being written.
作為上述水溶性纖維素衍生物,可較佳地使用經烷基及羥基烷基取代之纖維素醚或經羥基烷基取代之纖維素醚。As the above-mentioned water-soluble cellulose derivative, cellulose ethers substituted with alkyl groups and hydroxyalkyl groups or cellulose ethers substituted with hydroxyalkyl groups can be preferably used.
以上之水溶性高分子中,特佳為羥丙基纖維素(HPC)或羥丙基甲基纖維素(HPMC)、聚乙烯吡咯烷酮等之非極性水溶性高分子。該等對於塗佈之對象具有優異之固定性,由於與外部空氣接觸形成皮膜故乾燥性亦優異,進而由於形成之皮膜為水溶性,故擦除性亦優異。此外,可提供分散性能優異,於作為用於手術筆之墨水使用時之分散安定性、噴出性優異之墨水。Among the above water-soluble polymers, non-polar water-soluble polymers such as hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), and polyvinylpyrrolidone are particularly preferred. These have excellent fixability to the object to be coated, and are excellent in drying properties since they form a film when in contact with the outside air. Furthermore, since the formed film is water-soluble, they are also excellent in erasability. In addition, it is possible to provide an ink that has excellent dispersion properties and excellent dispersion stability and ejection properties when used as an ink for surgical pens.
該等水溶性高分子對於皮膚表皮或經切開之皮下組織、器官表面、肌肉、骨骼、口腔內、舌頭等具有良好固定性而可適當使用。其中最佳為固定性特別優異,被廣泛認為作為食品添加物之活體相容性,藉由與活性碳之相互作用展現出對γ射線之耐性,且具有高分散性能之聚乙烯吡咯烷酮。These water-soluble polymers have good fixation to the skin epidermis or incised subcutaneous tissue, organ surfaces, muscles, bones, oral cavity, tongue, etc. and can be used appropriately. The best among them is polyvinylpyrrolidone, which has excellent fixation properties, is widely regarded as a food additive, has in vivo compatibility, exhibits resistance to gamma rays through interaction with activated carbon, and has high dispersion properties.
水溶性高分子之添加量,於本發明中之特徵,係相對於碳材料100重量份包含20~200重量份。更佳為25~180重量份,最佳為30~150重量份。未達20重量%時,色材難以充分分散,於分散介質中碳材料之分散粒徑變大,於作為手術筆使用時,有於筆內部堵塞等而成為噴出不良的原因之虞。超過200重量份時,由於墨水黏度變高,故墨水變成不易自筆芯噴出,使書寫性下降。The added amount of the water-soluble polymer is characterized in the present invention and is 20 to 200 parts by weight relative to 100 parts by weight of the carbon material. More preferably, it is 25 to 180 parts by weight, and most preferably 30 to 150 parts by weight. When it is less than 20% by weight, it is difficult to fully disperse the color material, and the dispersed particle size of the carbon material in the dispersion medium becomes large. When used as a surgical pen, there is a risk of clogging inside the pen, etc., causing poor ejection. When the content exceeds 200 parts by weight, the viscosity of the ink becomes high, so the ink becomes difficult to eject from the pen core, resulting in decreased writing properties.
本發明之墨水發現藉由調配以上說明之特定水溶性高分子而可使碳材料安定且微細地分散,可適當地使用作為手術墨水。而且,藉由調配此等特定水溶性高分子,而使碳材料之色調顯現優異,於手術部位書寫時之密著性提高,對書寫對象物之固定良好,於手術中亦不會被擦除,可進行以濕紗布等任意擦拭即可擦除之優異黑色書寫。獲得此等優異效果之機制雖尚不完全清楚,但推測藉由與多孔性微細粉末之碳材料的親和性良好,與碳材料之粒子表面的極性相互作用,而有效率地助於防止於墨水中凝集,使粒子狀態安定化。It was found that the ink of the present invention can be stably and finely dispersed by blending the specific water-soluble polymer described above, and can be suitably used as a surgical ink. Moreover, by blending these specific water-soluble polymers, the carbon material has excellent color tone, improved adhesion when writing on the surgical site, good fixation of the writing object, and will not be erased during surgery. , can perform excellent black writing that can be erased by wiping with wet gauze. Although the mechanism for obtaining such excellent effects is not completely clear, it is speculated that the good affinity with the porous fine powder carbon material and the polar interaction with the particle surface of the carbon material effectively contribute to preventing the ink from forming. Aggregation in the medium stabilizes the particle state.
[分散介質] 本發明之特徵係作為分散介質係以水為主體。藉由以水為主體,可成為活體相容性、安全性、操作性方面優異之墨水。本發明之墨水構成中,即使作為分散介質係以水為主體時,分散狀態仍安定,可安定地維持手術筆書寫時之噴出性。本發明所用的水未特別限制,但較佳為作為醫療用而經適當品質管理之蒸餾水及注射用水等。 又此處所謂以水為主體,係指構成墨水的液體中之50重量%以上,更佳為60重量%以上為水。亦即本發明中,構成墨水之液體中之50重量%以上為水。特佳為作為以下說明之特定水溶性有機溶劑以外之液體成分實質上為水的組成。 本發明中若含有上述調配量以上的水,則除了水及水溶性有機溶劑以外亦可包含分散介質。該情況下,只要可使碳材料分散之液體,則未特別限制,只要根據用途適當選擇即可。 [dispersion medium] The characteristic of the present invention is that water is used as the main body as the dispersion medium. By using water as the main body, it can become an ink with excellent biocompatibility, safety, and operability. In the composition of the ink of the present invention, even when water is used as the main dispersion medium, the dispersion state remains stable, and the ejection property of the surgical pen during writing can be stably maintained. The water used in the present invention is not particularly limited, but is preferably distilled water and water for injection that have been appropriately quality-controlled for medical use. The term "water as the main body" here means that more than 50% by weight, more preferably more than 60% by weight, of the liquid constituting the ink is water. That is, in the present invention, more than 50% by weight of the liquid constituting the ink is water. Particularly preferred is a composition in which the liquid component other than the specific water-soluble organic solvent described below is substantially water. If the present invention contains water in an amount greater than the above-mentioned amount, a dispersion medium may be included in addition to water and a water-soluble organic solvent. In this case, the liquid is not particularly limited as long as the carbon material can be dispersed, and it can be appropriately selected according to the use.
[水溶性有機溶劑] 本發明中,希望含有特定水溶性有機溶劑作為水以外之液體成分。藉由添加該等水溶性有機溶劑,於使用手術筆,特別是標記筆方式之手術筆進行書寫時,除了具有防止筆芯部分堵塞之效果以外,亦可根據筆的構造調整墨水的乾燥性。作為此等水溶性有機溶劑之具體例,例如可使用選自甲醇、乙醇、正丙醇、異丙醇、正丁醇、異丁醇、第三丁醇、三羥甲基丙烷、乙二醇單乙醚、乙二醇單丁醚、單乙二醇、二乙二醇、三乙二醇、聚乙二醇、丙二醇、丁二醇、1,2,6-己烷三醇、硫代二醇、己二醇、甘油、雙甘油、1,2-己二醇、1,6-己二醇、2-吡咯烷酮、N-甲基-2-吡咯烷酮、1,5-戊二醇、單乙二醇單甲醚、單乙二醇單乙醚、單乙二醇單丁醚、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇二甲醚、二乙二醇單丁醚、三乙二醇單乙醚、三乙二醇二甲醚、三乙二醇單丁醚、乳酸甲酯、乳酸乙酯、1,3-二甲基-2-咪唑啉酮中,該等可單獨使用,亦可混合2種以上使用。作為食品添加物,特佳適用乙醇、異丙醇、聚乙二醇、丙二醇、甘油等。 [Water-soluble organic solvent] In the present invention, it is desirable to contain a specific water-soluble organic solvent as a liquid component other than water. By adding these water-soluble organic solvents, when writing with a surgical pen, especially a marker-type surgical pen, in addition to preventing partial clogging of the pen core, the dryness of the ink can also be adjusted according to the structure of the pen. Specific examples of such water-soluble organic solvents include methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, tert-butanol, trimethylolpropane, and ethylene glycol. Monoethyl ether, ethylene glycol monobutyl ether, monoethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, propylene glycol, butylene glycol, 1,2,6-hexanetriol, thiodiol Alcohol, hexanediol, glycerin, diglycerol, 1,2-hexanediol, 1,6-hexanediol, 2-pyrrolidone, N-methyl-2-pyrrolidone, 1,5-pentanediol, monoethyl Glycol monomethyl ether, monoethylene glycol monoethyl ether, monoethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol dimethyl ether, diethylene glycol monobutyl ether Ether, triethylene glycol monoethyl ether, triethylene glycol dimethyl ether, triethylene glycol monobutyl ether, methyl lactate, ethyl lactate, 1,3-dimethyl-2-imidazolinone, etc. Can be used alone or in combination of 2 or more types. As food additives, Tejia is suitable for ethanol, isopropyl alcohol, polyethylene glycol, propylene glycol, glycerin, etc.
水溶性有機溶劑之添加量,於本發明形態中墨水中較佳為5重量%至35重量%。更佳為10重量%至30重量%。若以多於35重量%之量添加,則墨水成為高黏度,除了墨水之安定性及噴出性降低以外,亦有乾燥速度變慢之情況。以未達5重量%添加時,作為手術筆使用時自筆芯之噴出有不安定之虞,且有發生滑開或堵塞等而使書寫性降低之情況。The amount of the water-soluble organic solvent added to the ink in the form of the present invention is preferably 5 to 35% by weight. More preferably, it is 10% by weight to 30% by weight. If it is added in an amount of more than 35% by weight, the ink will become highly viscous, and the stability and ejection properties of the ink will be reduced, and the drying speed may also be slowed down. If the content is less than 5% by weight, the ejection of the refill may be unstable when used as a surgical pen, and may cause slippage or clogging, resulting in reduced writing properties.
[表面張力調整劑] 本發明中,可根據需要使用表面張力調製劑。表面張力調製劑係具有提高自筆芯之噴出性與調整表面張力之作用的成分。作為表面張力調製劑之具體例,較佳為陰離子、非離子等之界面活性劑等,具體舉例為例如烷基苯磺酸鹽、高級醇硫酸酯鹽、高級脂肪酸鹽、高級烷基二羧酸鹽、烷基萘磺酸鹽、烷基磺基琥珀酸鹽、萘磺酸鹽甲醛縮合物鹽、聚氧乙烯烷基醚硫酸鹽、聚乙氧烯烷基磷酸酯等之陰離子系界面活性劑;例如聚氧乙烯烷基醚、聚氧乙烯烷基苯基醚、脂肪酸單甘油酯、山梨糖醇酐脂肪酸酯、蔗糖脂肪酸酯、聚氧乙烯山梨糖醇酐脂肪酸酯、聚氧乙烯脂肪酸酯、甘油脂肪酸酯、聚氧乙烯加成乙炔二醇等之非離子系界面活性劑、矽氧系界面活性劑、氟系界面活性劑、乙醇、異丙醇等之水溶性有機溶劑。 表面張力調整劑之添加量只要根據所需之表面張力適當選擇即可,但較佳於墨水中為0.5~30重量%,特佳為1~20重量%。 [Surface tension adjuster] In the present invention, a surface tension modulator can be used as necessary. The surface tension modulator is a component that improves the ejection properties of the pen core and adjusts the surface tension. Specific examples of the surface tension modulator are preferably anionic, nonionic, etc. surfactants, and specific examples include alkyl benzene sulfonates, higher alcohol sulfate ester salts, higher fatty acid salts, and higher alkyl dicarboxylic acids. Anionic surfactants such as salts, alkyl naphthalene sulfonates, alkyl sulfosuccinates, naphthalene sulfonate formaldehyde condensate salts, polyoxyethylene alkyl ether sulfates, polyethoxyethylene alkyl phosphates, etc. ;For example, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, fatty acid monoglyceride, sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene Non-ionic surfactants such as fatty acid esters, glycerol fatty acid esters, polyoxyethylene-added acetylene glycol, etc., silicone-based surfactants, fluorine-based surfactants, water-soluble organic solvents such as ethanol and isopropyl alcohol . The amount of surface tension adjuster added can be appropriately selected according to the required surface tension, but it is preferably 0.5 to 30% by weight in the ink, and particularly preferably 1 to 20% by weight.
[鹼性物質] 本發明中為了將pH調整於特定範圍內,可於墨水中存在鹼性物質。本發明之墨水組成中,由於有因碳材料使墨水顯示酸性之傾向,故若不進行利用鹼性物質之中和,則有根據部位而對活體的刺激性變強之情況。活體之適宜pH範圍因部位而異,但本發明中,藉由適當調節鹼性物質之添加量,可配合欲標記的部位將pH調整於適當範圍,可減低刺激性。 作為本發明之鹼性物質,只要為阿瑞尼斯(Arrhenius)之定義中顯示鹼性之物質中具有活體相容性者則未特別限制,但較佳為藉由少量添加即可使pH大幅改變,進而為可食之碳酸鈉、氫氧化鈉,碳酸鉀、碳酸氫鈉等之pH調整劑。該等中特佳為碳酸鈉、氫氧化鈉,最佳為氫氧化鈉。 [alkaline substance] In the present invention, in order to adjust the pH within a specific range, an alkaline substance may be present in the ink. In the ink composition of the present invention, the carbon material tends to make the ink acidic. Therefore, if the ink is not neutralized with an alkaline substance, the irritation to the living body may become stronger depending on the location. The suitable pH range of a living body varies depending on the site. However, in the present invention, by appropriately adjusting the amount of alkaline substances added, the pH can be adjusted to an appropriate range according to the site to be marked, thereby reducing irritation. The alkaline substance of the present invention is not particularly limited as long as it is alkaline in the definition of Arrhenius and has biocompatibility. However, it is preferably one that can significantly change the pH by adding a small amount. , and then become a pH adjuster for edible sodium carbonate, sodium hydroxide, potassium carbonate, sodium bicarbonate, etc. Among them, sodium carbonate and sodium hydroxide are particularly preferred, and sodium hydroxide is the most preferred.
特別是作為手術筆用墨水使用時,該等中最佳為氫氧化鈉。藉由添加氫氧化鈉,即使為如活性碳等之難分散性之顏料,墨水中粒子的分散狀態仍安定,可防止於筆尖之堵塞等之噴出不良及因長期保存所致之變質、沉澱、固化、增粒、增黏等。 氫氧化鈉有助於分散狀態安定化之機制尚不清楚,但認為碳材料粒子之表面活性安定化展現防止凝集之效果。 Especially when used as an ink for surgical pens, sodium hydroxide is the most preferred among these. By adding sodium hydroxide, even for difficult-to-disperse pigments such as activated carbon, the dispersed state of particles in the ink remains stable, preventing ejection failures such as clogging of the pen tip and deterioration, sedimentation, etc. caused by long-term storage. Curing, granulation increasing, viscosity increasing, etc. The mechanism by which sodium hydroxide contributes to the stabilization of the dispersed state is not yet clear, but it is thought that the surface active stabilization of carbon material particles exhibits the effect of preventing aggregation.
鹼性物質於墨水100重量份中較佳含有0.01~1.00重量份,更佳含有0.05~0.50重量份。鹼性物質若少於0.01重量份,則pH變化不足,且使用氫氧化鈉時無法充分展現分散狀態安定化之效果。添加量若多於1.00重量份,則超出適於活體之範圍使pH變高而有刺激較強之情況。The alkaline substance preferably contains 0.01~1.00 parts by weight in 100 parts by weight of the ink, and more preferably contains 0.05~0.50 parts by weight. If the alkaline substance is less than 0.01 parts by weight, the pH change will be insufficient, and the effect of stabilizing the dispersed state cannot be fully demonstrated when sodium hydroxide is used. If the amount added is more than 1.00 parts by weight, the pH will exceed the range suitable for living organisms and the pH will be high, resulting in strong stimulation.
此外,為了調整墨水黏度、提高密著性等其他目的,可於不妨礙本發明之性能之範圍,適當添加水溶性高分子等其他成分。例如亦可添加瓜爾膠、刺槐豆膠、瓊脂、甲基澱粉等之澱粉系、明膠、支鏈澱粉、黃原膠、西黄蓍膠、糊精、酪蛋白、水溶性纖維素衍生物、聚乙烯醇、聚乙烯吡咯烷酮等之非極性水溶性高分子。In addition, for other purposes such as adjusting the viscosity of the ink, improving adhesion, etc., other components such as water-soluble polymers may be appropriately added within the range that does not hinder the performance of the present invention. For example, starches such as guar gum, locust bean gum, agar, and methyl starch, gelatin, amylopectin, xanthan gum, tragacanth gum, dextrin, casein, and water-soluble cellulose derivatives may also be added. Non-polar water-soluble polymers such as polyvinyl alcohol and polyvinylpyrrolidone.
又,本發明之墨水雖特徵係含有碳材料作為色材,但在不妨礙本發明性能之範圍,含有其他色材亦無妨。Furthermore, although the ink of the present invention is characterized by containing a carbon material as a color material, it does not matter if it contains other color materials as long as it does not impede the performance of the present invention.
[墨水之特徵] 本發明之墨水中的碳材料之平均分散粒徑為50nm~1μm,較佳為50~800nm,更佳為50~700nm,又更佳為50~600nm,再更佳為50~500nm,又再更佳為100~450nm,最佳為150~400nm。於上述較佳範圍內,著色力、分散安定性、固定性、噴出性優異,但於50~500nm、100~450nm及150~400nm之範圍,無論筆構件或筆芯如何,上述各性能均特別優異。平均分散粒徑未達50nm時,因粒子彼此之凡德瓦爾力,而容易發生凝集,有經時安定性降低之傾向。平均分散粒徑超過1μm時,液體中之色材容易分離,變成有容易引起沉澱之情況。 [Characteristics of ink] The average dispersed particle size of the carbon material in the ink of the present invention is 50nm~1μm, preferably 50~800nm, more preferably 50~700nm, more preferably 50~600nm, still more preferably 50~500nm, and still more preferably 50~500nm. More preferably, it is 100~450nm, and the most optimal is 150~400nm. Within the above-mentioned preferred range, the tinting strength, dispersion stability, fixation, and ejection properties are excellent. However, in the ranges of 50~500nm, 100~450nm, and 150~400nm, the above-mentioned properties are exceptional regardless of the pen components or refills. Excellent. When the average dispersed particle size is less than 50 nm, aggregation is likely to occur due to van der Waals forces between particles, and the stability tends to decrease over time. When the average dispersed particle size exceeds 1 μm, the color material in the liquid is likely to separate and may easily cause precipitation.
又,較佳不僅控制平均分散粒徑,亦抑制粗大粒子之量。具體而言,針對液體中全碳材料粒子之90%以上,將分散粒徑調整為1μm以下,更佳為500nm以下,則可獲得更優異物性之墨水。作為調整方法,亦考慮進行分散處理直至全碳材料粒子之90%以上成為分散粒徑1μm以下,更佳為500nm以下,但為了防止大量發生過細的粒子而再凝集,於進行分散處理直至平均分散粒徑為1μm以下,更佳為500nm以下之後,藉由離心或過濾器過濾等之習知方法去除粗大粒子之方法亦適宜。Furthermore, it is preferable to control not only the average dispersed particle size but also the amount of coarse particles. Specifically, if more than 90% of the total carbon material particles in the liquid are adjusted to have a dispersed particle size of 1 μm or less, and more preferably 500 nm or less, ink with better physical properties can be obtained. As an adjustment method, it is also considered to conduct dispersion treatment until more than 90% of the total carbon material particles have a dispersed particle size of 1 μm or less, more preferably 500 nm or less. However, in order to prevent a large number of excessively fine particles from being reaggregated, the dispersion treatment is performed until evenly dispersed After the particle size is 1 μm or less, more preferably 500 nm or less, conventional methods such as centrifugation or filter filtration to remove coarse particles are also suitable.
又,本發明中平均分散粒徑及全粒子之分散粒徑之測定方法如下,但若可獲得相同結果,則不限於此。 調整(conditioning):以離子交換水稀釋原液,以使其落入每測定機器規定之測定濃度區域。 測定機器:動態光散射式粒度分佈測定器(「NIKKISO:Microlracwave-EX150」) 測定時間:120秒 In addition, in the present invention, the method for measuring the average dispersed particle size and the dispersed particle size of all particles is as follows, but if the same result can be obtained, it is not limited to this. Conditioning: Dilute the original solution with ion-exchange water so that it falls into the measurement concentration area specified by each measurement machine. Measuring machine: Dynamic light scattering particle size distribution analyzer ("NIKKISO: Microlracwave-EX150") Measurement time: 120 seconds
本發明之墨水的黏度較佳為1.0~10.0mPa·s。更佳為1.5~9.0mPa·s,最佳為2.0~8.0mPa·s。黏度未達1.0mPa·s時,作為手術筆使用時有過多墨水自筆芯流出之情況。相反地,黏度超過10.0mPa·s時,墨水不易自筆芯流出而成為模糊之原因。 又,一般使用顏料之墨水以標記筆方式的筆使用時,若將筆尖朝下長期間保存,則顏料會沉澱而在筆尖附近堆積、固化,而使筆尖堵塞,產生模糊/色淺等之書寫性降低之虞,但藉由於上述範圍內提高墨水黏度,可使顏料沉澱之速度降低,可抑制書寫性降低。 The viscosity of the ink of the present invention is preferably 1.0~10.0mPa·s. More preferably, it is 1.5~9.0mPa·s, and most preferably, it is 2.0~8.0mPa·s. When the viscosity is less than 1.0 mPa·s, too much ink may flow out of the pen core when used as a surgical pen. On the contrary, when the viscosity exceeds 10.0 mPa·s, the ink will not easily flow out of the pen core, causing blurring. In addition, when using a marker-style pen that generally uses pigmented ink, if the pen tip is stored for a long time, the pigment will precipitate and accumulate near the pen tip, solidifying, causing the pen tip to become clogged, resulting in blurry/light-colored writing. There is a risk of reduced writing properties, but by increasing the viscosity of the ink within the above range, the speed of pigment precipitation can be reduced, thereby suppressing the deterioration of writing properties.
本發明中黏度之測定方法如下,但若為可獲得相同結果則不限於此。 調整:原液 測定機器:圓錐平板型旋轉黏度計(東機基產業(股)製「TVE-20L型」) 測定條件:50rpm 測定溫度:25℃ The measuring method of viscosity in the present invention is as follows, but it is not limited to this if the same result can be obtained. Adjustment: stock solution Measuring equipment: Cone plate type rotational viscometer ("TVE-20L type" manufactured by Toki Industrial Co., Ltd.) Measurement conditions: 50rpm Measuring temperature: 25℃
本發明之墨水的特徵係pH值為4.0至11.0。在此範圍外,由於對活體之刺激性強故無法作為手術墨水使用。活體之多數部位中,更佳為pH6.0至9.0,但藉由根據欲塗佈之部位調整為適當值可減低刺激性。 pH之測定方法未特別限制,但可以如下進行。 調整:原液 測定機器:pH測定器(東亞DKK(股)製「MH-41X型」) 測定溫度:25℃ The ink of the present invention is characterized by a pH value of 4.0 to 11.0. Outside this range, it cannot be used as surgical ink because it is highly irritating to living organisms. In most parts of the living body, a pH of 6.0 to 9.0 is preferred, but irritation can be reduced by adjusting to an appropriate value according to the part to be coated. The method of measuring pH is not particularly limited, but can be performed as follows. Adjustment: stock solution Measuring device: pH meter ("MH-41X type" manufactured by DKK East Asia Co., Ltd.) Measuring temperature: 25℃
本發明之墨水可成為具有γ射線耐性者。亦即,如後述實施例所示,本發明之墨水之物性於γ射線前後幾乎沒有變化,即使在γ射線照射後仍可長期間保持安定品質。具體而言,根據JIS/ISO標準(JIS T 0806-1/ISO 11137-1及JIS T 0806-2/ISO 11137-2),即使以吸收劑量25kGy~70kGy進行γ射線照射處理後,平均分散粒徑、黏度、pH仍可保持在前述較佳範圍內,進而平均分散粒徑、黏度、pH可保持在前述最佳範圍內。 如前所述,此係推測藉由包含碳材料使碳材料發揮遮罩γ射線,防止水溶性高分子等之其他構成物變質之作用,該效果於碳材料為活性碳,水溶性高分子為聚乙烯吡咯烷酮之情形時特別顯著,此亦由本發明人等之檢討所了解到者,且亦可由後述實施例證實。 藉由具有γ射線耐性,即使為了手術筆之滅菌而進行之γ射線照射,墨水亦不會變質,可維持作為手術墨水之較佳物性,不會發生噴出不良等之問題而可進行標記、書寫。 The ink of the present invention can be resistant to gamma rays. That is, as shown in the examples described below, the physical properties of the ink of the present invention hardly change before and after gamma rays, and the ink can maintain stable quality for a long time even after gamma ray irradiation. Specifically, according to JIS/ISO standards (JIS T 0806-1/ISO 11137-1 and JIS T 0806-2/ISO 11137-2), even after gamma ray irradiation treatment with an absorbed dose of 25 kGy to 70 kGy, the average dispersed particles The diameter, viscosity, and pH can still be maintained within the aforementioned optimal ranges, and the average dispersed particle size, viscosity, and pH can be maintained within the aforementioned optimal ranges. As mentioned above, it is speculated that by including the carbon material, the carbon material can shield gamma rays and prevent other components such as water-soluble polymers from deteriorating. This effect occurs when the carbon material is activated carbon and the water-soluble polymer is The situation of polyvinylpyrrolidone is particularly remarkable. This was also found out by the inventors' review and can also be confirmed by the examples described below. By having gamma ray resistance, the ink will not deteriorate even if it is irradiated with gamma rays to sterilize the surgical pen, maintaining optimal physical properties as a surgical ink, and marking and writing can be performed without problems such as poor ejection. .
25kGy~70kGy之吸收劑量係對本發明之手術墨水及使用其之手術筆共通而確保無菌性之劑量,係根據滅菌驗證(JIS T 0806-1/ISO 11137-1及JIS T 0806-2/ISO 11137-2)之規定,經過(1)材質試驗、(2)生物負荷(Bioburden)測定、(3)滅菌劑量設定試驗、(4)無菌試驗、(5)劑量分佈評價而決定。(1)生物負荷測定及(4)無菌性試驗分別基於JIS/ISO標準「製品上之微生物菌落之測定方法」(JIS T 11737-1/ISO 11737-1)及「滅菌製程之定義、驗證及維持中實施之無菌性試驗」(JIS T 11737-2/ISO 11737-2)。 亦即,無菌性保證水準(sterility assurance level:SAL)為10-6,基於藉由(1)生物負荷測定及(4)無菌性試驗所得之於每單位被照射物中存活之微生物數及其致死速度(為了將細菌數減少到10分之1所需之時間:D值),決定達到SAL之γ射線的吸收劑量。換言之,為了確保無菌性之γ射線照射時間為達到SAL之達成γ射線吸收劑量所需之時間(2~3小時左右)以上。 本發明中吸收劑量設為25kGy~70kGy,更佳為25kGy~45kGy。吸收劑量少於25kGy時,無法確保無菌性,大於70kGy時,助長了放射線劣化,有使墨水的性狀不經意變性之虞。 吸收劑量範圍25kGy~70kGy係設為可對應於箱內之各個被滅菌物所收納配置之位置與線源之相對距離之誤差,且針對填充有本發明之手術墨水之手術筆,設為於保證(4)無菌性試驗之無菌性並且保證(1)材質試驗之機械強度的範圍。 The absorbed dose of 25kGy~70kGy is a dose common to the surgical ink of the present invention and the surgical pen using it to ensure sterility, and is based on sterilization verification (JIS T 0806-1/ISO 11137-1 and JIS T 0806-2/ISO 11137 The regulations of -2) are determined through (1) material test, (2) bioburden measurement, (3) sterilization dose setting test, (4) sterility test, and (5) dose distribution evaluation. (1) Bioburden determination and (4) Sterility test are based on the JIS/ISO standards "Method for determination of microbial colonies on products" (JIS T 11737-1/ISO 11737-1) and "Definition, verification and verification of sterilization processes" respectively. Sterility test performed during maintenance" (JIS T 11737-2/ISO 11737-2). That is, the sterility assurance level (SAL) is 10-6, based on the number of viable microorganisms per unit of irradiated object obtained through (1) bioburden determination and (4) sterility test. The lethal speed (the time required to reduce the number of bacteria to 1/10: D value) determines the absorbed dose of gamma rays that reaches SAL. In other words, in order to ensure sterility, the γ-ray irradiation time is longer than the time required to achieve the γ-ray absorbed dose to achieve SAL (about 2 to 3 hours). In the present invention, the absorbed dose is set to 25kGy~70kGy, more preferably 25kGy~45kGy. When the absorbed dose is less than 25 kGy, sterility cannot be ensured. When it exceeds 70 kGy, radiation deterioration is accelerated and the properties of the ink may be inadvertently denatured. The absorbed dose range of 25kGy~70kGy is set to correspond to the error in the relative distance between the position of each sterilized object in the box and the line source, and is set to ensure that the surgical pen filled with the surgical ink of the present invention is (4) The sterility of the sterility test and the range of the mechanical strength of the (1) material test are guaranteed.
本發明之墨水在墨水製造後較佳進行γ射線照射處理。具體而言,較佳於墨水製造後,根據JIS/ISO標準(JIS T 0806-1/ISO 11137-1及JIS T 0806-2/ISO 11137-2),以25kGy~70kGy之吸收劑量進行γ射線照射處理,吸收劑量更佳為25kGy~45kGy。藉由在上述範圍內進行γ射線照射處理,可將墨水滅菌,可成為擔保作為手術用之安全性之墨水,且不易因放射線劣化所致之墨水物性之變性及不易發生欲填充之手術筆的機械強度降低。 γ射線照射處理所用之方法及條件,只要符合上述標準,則未特別限制,但可藉由下述進行γ射線照射處理。 ・γ射線照射處理: 放射性核種:Co60 照射設施:日本照射服務股份有限公司 東海中心內 照射容器:箱(78×50×150cm) 照射裝置:(型式)JS10000HD,IR-199(製造源)MDS Nordion 設定目標吸收劑量:50kGy(實測值54.0kGy~67.6 kGy) 照射時間:26,000秒 The ink of the present invention is preferably subjected to gamma ray irradiation treatment after the ink is produced. Specifically, it is better to perform gamma rays with an absorbed dose of 25kGy~70kGy according to JIS/ISO standards (JIS T 0806-1/ISO 11137-1 and JIS T 0806-2/ISO 11137-2) after the ink is produced. For irradiation treatment, the optimal absorbed dose is 25kGy~45kGy. By performing gamma ray irradiation treatment within the above range, the ink can be sterilized, and the ink can be guaranteed to be safe for use in surgeries, and it is less likely to change the physical properties of the ink due to radiation degradation and is less likely to cause the surgical pen to be filled. Mechanical strength is reduced. The method and conditions used in the gamma ray irradiation treatment are not particularly limited as long as they meet the above standards, but the gamma ray irradiation treatment can be performed as follows. ・γ-ray irradiation treatment: Radioactive nuclide: Co60 Irradiation facility: Nippon Irradiation Services Co., Ltd., inside Tokai Center Irradiation container: box (78×50×150cm) Irradiation device: (Type) JS10000HD, IR-199 (Manufacturing source) MDS Nordion Set target absorbed dose: 50kGy (actual measured value 54.0kGy~67.6 kGy) Irradiation time: 26,000 seconds
本發明之墨水可成為即使長期保存物性亦不會劣化者。具體而言,於室溫保存時,於製作後較佳經過30天以上之後,平均分散粒徑、黏度、pH在上述較佳範圍內,更佳經過60天以上之後,該等在上述較佳範圍內,最佳即使經過90天以上之後,該等仍可在上述較佳範圍內。 由於即使長期保存中仍可將上述物性保持在較佳範圍內,故即填充於筆中予以保存之情況,亦不損及噴出性及書寫感、低刺激性而可進行安定的書寫。 The ink of the present invention can have physical properties that do not deteriorate even if stored for a long period of time. Specifically, when stored at room temperature, preferably after more than 30 days after production, the average dispersed particle size, viscosity, and pH are within the above-mentioned preferred ranges, and more preferably after more than 60 days, these are within the above-mentioned preferred ranges. Within the range, it is best that even after more than 90 days have passed, they can still be within the above-mentioned better range. Since the above-mentioned physical properties can be maintained within an optimal range even during long-term storage, even when filled in a pen and stored, the ejection properties and writing feel are not impaired, and stable writing is possible with low irritation.
[墨水之製造] 本發明之墨水之製造方法未特別限制,只要將前述之各成分混合作成墨水即可。作為一例,係將碳材料、水溶性高分子與水混合攪拌後,使用市售之分散機例如塗料振動器、輥磨機、球磨機、砂磨機、噴射磨機等分散後,適當添加上述說明之水溶性有機溶劑及表面張力調整劑等之各種添加劑並墨水化。 又,藉由對由上述製造之墨水藉由習知方法實施過濾器處理、磁選處理、雜質離子去除處理等,亦可進一步提高品質。此外,上述製造方法中,於將碳材料、水溶性高分子與水混合攪拌、分散後,亦加上去除粗大粒子之步驟,可有效製造安定維持良好分散狀態之墨水。添加鹼性物質時,其方法及時點未特別限制。例如,於將水、碳材料及水溶性高分子混合攪拌時與其一起添加,或者在分散處理後與水溶性有機溶劑及表面張力調整劑等之添加劑一起添加。 實施γ射線照射處理時,於由上述製造墨水後進行。亦可使墨水於聚乙烯容器等之有γ射線耐性之容器中,進行γ射線照射,亦可填充於任意筆中作成手術筆後進行。 [Making of Ink] The manufacturing method of the ink of the present invention is not particularly limited, as long as the above-mentioned components are mixed to prepare the ink. As an example, the carbon material, water-soluble polymer and water are mixed and stirred, and then dispersed using a commercially available disperser such as a paint vibrator, roller mill, ball mill, sand mill, jet mill, etc., and then the above instructions are appropriately added. Various additives such as water-soluble organic solvents and surface tension adjusters are used to form inks. Furthermore, the quality can be further improved by subjecting the ink produced as described above to filter treatment, magnetic separation treatment, impurity ion removal treatment, etc. by conventional methods. In addition, in the above-mentioned manufacturing method, after the carbon material, water-soluble polymer and water are mixed, stirred and dispersed, a step of removing coarse particles is also added, so that ink that is stable and maintains a well-dispersed state can be effectively manufactured. When adding an alkaline substance, the method and time are not particularly limited. For example, it is added together with water, carbon materials, and water-soluble polymers when they are mixed and stirred, or added together with additives such as water-soluble organic solvents and surface tension adjusters after dispersion treatment. When the gamma ray irradiation treatment is performed, it is performed after the ink is produced as described above. The ink can also be placed in a container that is resistant to gamma rays, such as a polyethylene container, and then irradiated with gamma rays, or it can be filled into any pen to make a surgical pen.
[使用方法及用途] 使用以上說明之本發明之墨水,可塗佈、書寫於各種對象物。例如,將本發明之墨水附著於竹串、棉棒、筆、刮板等的前端,將其塗佈於欲標記之部位,可實施手術標記。且,藉由填充於手術筆進行書寫,可調整線寬及點大小而可實施更精確之標記。用於手術筆時,筆的種類及書寫方法未特別限制,可將過去以來作為文具而使用之標記、簽字筆、塑膠筆等之書寫工具予以消毒而使用,但基於書寫性方面,較佳使用於γ射線照射處理後筆構件亦不變質可確保充分的機械強度與噴出性的筆。筆中,以標記筆方式的筆雖墨水流路特別細密,且使用顏料之墨水於噴出性等之書寫性容易成為問題,但在本發明中,藉由組合前述構成物,由於可展現適於書寫之物性,故可較佳地使用。 由於本發明之墨水僅由具有活體相容性且於體內可安全地攝取的成分構成,故亦可較佳地使用於手術墨水以外之需要活體相容性之用途,例如對化妝品、衛生用品、食品、玩具、嬰兒用品、醫藥品等之書寫、加飾、印刷等。 又,由於著色性、固定性優異,故於上述用途中可基於防偽,可追溯性之記錄、防誤食等之注意事項的顯示、提高識別性、賦予設計性及娛樂性等之各種目的中使用。 [實施例] [How to use and purpose] Using the ink of the present invention described above, it is possible to apply and write on various objects. For example, surgical marking can be performed by attaching the ink of the present invention to the tip of a bamboo skewer, cotton swab, pen, scraper, etc., and applying it to the area to be marked. Furthermore, by filling in the surgical pen and writing, the line width and point size can be adjusted, allowing for more precise marking. When used for surgical pens, the type of pen and writing method are not particularly limited. Writing tools such as markers, roller pens, and plastic pens that have been used as stationery in the past can be sterilized and used. However, in terms of writing properties, it is better to use The pen components do not deteriorate even after gamma ray irradiation treatment, ensuring sufficient mechanical strength and ejection properties of the pen. Among pens, pens in the form of marker pens have particularly fine ink flow paths, and inks using pigments tend to have problems with writing properties such as ejection properties. However, in the present invention, by combining the aforementioned structures, it is possible to demonstrate a suitable It has the physical properties of writing, so it can be used better. Since the ink of the present invention is composed only of ingredients that are biocompatible and can be safely ingested in the body, it can also be preferably used in applications other than surgical inks that require biocompatibility, such as cosmetics, sanitary products, Writing, decoration, printing, etc. for food, toys, baby products, pharmaceuticals, etc. In addition, because it has excellent coloring and fixing properties, it can be used for various purposes such as anti-counterfeiting, traceability recording, display of precautions such as accidental ingestion, improvement of visibility, design and entertainment, etc. use. [Example]
以下例舉實施例詳細說明本發明。實施例中,「份」均表示重量份。The following examples illustrate the present invention in detail. In the examples, "parts" all represent parts by weight.
[實施例1] ・分散液之製造 調配以下所示之成分,在室溫下以螺旋翼攪拌機攪拌1小時。 成分 量 (重量份(以下稱為份)) 活性碳 10.0 (平均粒徑;35μm、平均細孔直徑;3.4nm) 聚乙烯吡咯烷酮 7.22 (黏度平均分子量;5萬) 水 82.78 [Example 1] ・Manufacture of dispersion liquid Prepare the ingredients shown below and stir with a propeller mixer at room temperature for 1 hour. Ingredients Quantity (Parts by weight (hereinafter referred to as parts)) Activated carbon 10.0 (Average particle size: 35μm, average pore diameter: 3.4nm) Polyvinylpyrrolidone 7.22 (Viscosity average molecular weight; 50,000) Water 82.78
其次,對於所得之混合物,將150g直徑0.5mm之氧化鋯珠放入塗料搖晃用鍋中進行振動3小時。 將該分散液中所含之粗大粒子予以去除處理,調整為全粒子之90%以上的分散粒徑為500nm以下,固形分濃度為10重量%,作為「分散液1」。 Next, 150 g of zirconia beads with a diameter of 0.5 mm were placed into a paint shaking pot for the resulting mixture and vibrated for 3 hours. The coarse particles contained in this dispersion were removed, and the dispersed particle diameter of more than 90% of the total particles was adjusted to 500 nm or less, and the solid content concentration was 10% by weight, which was designated as "dispersion 1".
・墨水化 其次,將以下調配以螺旋翼攪拌機在室溫攪拌30分鐘,獲得墨水。 成分 量(份) 分散液1(固形分10%) 68.03 丙二醇 5.0 水 26.97 所得墨水之平均分散粒徑為274nm,黏度為2.5mPa·s,pH為5.1。又所得墨水外觀上顯示均勻的黑色。進而,針對上述墨水依據以下方法試驗經時安定性、書寫性、固定性、耐水性並評價。其結果示於表1。 ・Ink Secondly, stir the following mixture with a propeller mixer at room temperature for 30 minutes to obtain ink. Ingredients Quantity (portions) Dispersion 1 (solid content 10%) 68.03 Propylene Glycol 5.0 Water 26.97 The average dispersed particle size of the obtained ink was 274 nm, the viscosity was 2.5 mPa·s, and the pH was 5.1. The resulting ink appears uniformly black. Furthermore, the above-mentioned ink was tested and evaluated for stability over time, writing properties, fixability, and water resistance according to the following methods. The results are shown in Table 1.
(a)經時安定性試驗 將墨水放於聚乙烯瓶中,於25℃之恆溫室中靜置1個月後,確認有無色材分離、水浮及沉澱。色材分離、水浮及沉澱輕微發生之狀態亦評價為異常。 表1中,無異常時記為○,雖見到異常,但用勺子輕輕攪拌可將分離、水浮及沉澱改善至與無異常相同程度者記為△,見到異常及使用勺子輕輕攪拌亦無法將分離、水浮及沉澱改善至與無異常相同程度者記為×。 (a) Time stability test Put the ink in a polyethylene bottle and let it stand for 1 month in a constant temperature room at 25°C. Check whether there is separation, water floating and sedimentation of the colorless material. The state in which color materials separate, water floats, and settles slightly occurs is also evaluated as abnormal. In Table 1, if there is no abnormality, it is marked as ○. Although there is an abnormality, if the separation, water floating and sedimentation can be improved to the same degree as if there is no abnormality by gently stirring with a spoon, it is marked as △. If there is an abnormality and gently stirring with a spoon, it is marked as △. Those that cannot improve separation, water flotation, and sedimentation to the same level as no abnormality despite stirring are marked as ×.
(b)書寫性試驗 於筆尖使用由聚胺基甲酸酯樹脂黏結PET樹脂纖維束所成之前端作為略半球狀之纖維束芯(直徑12mm)之棉絮式標記筆中填充墨水,於乾燥的手背皮膚及雞骨上進行書寫,針對墨水可否自筆芯部噴出、描繪線可否視認性及書寫後經過30分鐘後可否再書寫進行調查。 於墨水剛填充後可噴出,描繪線可明確視認,即使經過30分鐘後亦可再書寫時於表1中記為○,該等中任何一者為否時記為×。 (b) Writing test Fill the pen tip with ink into a cotton-wool type marker pen made of polyurethane resin bonded PET resin fiber bundles with a slightly hemispherical fiber bundle core (diameter 12mm) at the tip, and apply it on the dry back skin and chicken bones of the hand. While writing, check whether ink can be ejected from the pen core, whether the drawn line is visible, and whether writing can be continued after 30 minutes. If the ink can be ejected immediately after filling, the drawn line can be clearly recognized, and it can be written again even after 30 minutes, it is marked as ○ in Table 1. If any of these is not true, it is marked as ×.
(c)固定性/乾燥性試驗 於上述(b)書寫性試驗中使用之標記筆中填充墨水,書寫於乾燥的手背皮膚上,以乾的不織布擦拭書寫部3次,調查墨水有無伸展以及墨水有無轉印到不織布。 無墨水伸展且亦無轉印到不織布時於表1中記為○,該等中任一者未滿足時記為×。 (c)Fixity/drying test Fill the marker pen used in the above (b) writing test with ink, write on the dry skin of the back of your hand, wipe the writing part three times with a dry non-woven fabric, and check whether the ink stretches and whether the ink transfers to the non-woven fabric. When there is no ink stretching and no transfer to the nonwoven fabric, it is marked as ○ in Table 1. When any of these conditions are not satisfied, it is marked as ×.
(d)耐水性試驗 於上述(b)書寫性試驗中使用之標記筆中填充墨水,書寫於乾燥的手背皮膚上,10分鐘後以自來水的水流沖洗書寫部1分鐘,調查有無書寫描繪線之視認性及有無滲開。 可明確視認到書寫描繪線,且未確認到滲開或擴散到周邊時於表1中記為○,該等中任一者未滿足時記為×。 (e)顯色試驗 於(d)之試驗中進行書寫後之描繪線部以目視確認,確認可否判別描繪線及色調。 可判別為黑色乃至深灰色且描繪線良好者於表1中記為○,無法判別者記為×。 (d) Water resistance test Fill the marker pen used in the above (b) writing test with ink and write on the dry skin of the back of your hand. After 10 minutes, rinse the writing part with tap water for 1 minute and check whether there is visibility of the written line and whether there is bleeding. . When the written and drawn lines are clearly visible and bleeding or spreading to the periphery is not confirmed, it is marked as ○ in Table 1. When either of these conditions is not satisfied, it is marked as ×. (e) Color development test In the test of (d), visually confirm the drawn line after writing to confirm whether the drawn line and color tone can be distinguished. Those that can be distinguished as black or even dark gray and have good drawing lines are marked as ○ in Table 1, and those that cannot be distinguished are marked as ×.
[實施例2] 實施例1中,除了將墨水化時之組成設為如下以外,同樣製造墨水。 成分 量(份) 分散液1(固形分10%) 68.03 丙二醇 5.0 乙醇 15.0 水 11.97 所得墨水之平均分散粒徑為313nm,黏度為4.3mPa·s,pH為4.9。又所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,以與實施例1同樣進行評價。其結果示於表1。 [Example 2] In Example 1, the ink was produced in the same manner except that the composition when converted into ink was as follows. Ingredients Quantity (portions) Dispersion 1 (solid content 10%) 68.03 Propylene Glycol 5.0 Ethanol 15.0 Water 11.97 The average dispersed particle size of the obtained ink was 313 nm, the viscosity was 4.3 mPa·s, and the pH was 4.9. The resulting ink is uniformly black in appearance. Furthermore, the above-mentioned ink was evaluated in the same manner as in Example 1. The results are shown in Table 1.
[實施例3] 實施例1中,除了將墨水化時之組成設為如下以外,同樣製造墨水。 成分 量(份) 分散液1(固形分10%) 75.83 丙二醇 5.0 碳酸鈉 0.0064 水 19.16 所得墨水之平均分散粒徑為352nm,黏度為2.8mPa·s,pH為6.1。又所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,以與實施例1同樣進行評價。其結果示於表1。 [Example 3] In Example 1, the ink was produced in the same manner except that the composition when converted into ink was as follows. Ingredients Quantity (portions) Dispersion 1 (solid content 10%) 75.83 Propylene Glycol 5.0 Sodium carbonate 0.0064 Water 19.16 The average dispersed particle size of the obtained ink was 352 nm, the viscosity was 2.8 mPa·s, and the pH was 6.1. The resulting ink is uniformly black in appearance. Furthermore, the above-mentioned ink was evaluated in the same manner as in Example 1. The results are shown in Table 1.
[實施例4] 實施例1中,除了將墨水化時之組成設為如下以外,同樣製造墨水。 成分 量(份) 分散液1(固形分10%) 75.83 丙二醇 5.0 乙醇 15.0 碳酸鈉 0.0064 水 4.16 所得墨水之平均分散粒徑為300nm,黏度為5.1mPa·s,pH為6.2。又所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,以與實施例1同樣進行評價。其結果示於表1。 [Example 4] In Example 1, the ink was produced in the same manner except that the composition when converted into ink was as follows. Ingredients Quantity (portion) Dispersion 1 (solid content 10%) 75.83 Propylene Glycol 5.0 Ethanol 15.0 Sodium carbonate 0.0064 Water 4.16 The average dispersed particle size of the obtained ink was 300 nm, the viscosity was 5.1 mPa·s, and the pH was 6.2. The resulting ink is uniformly black in appearance. Furthermore, the above-mentioned ink was evaluated in the same manner as in Example 1. The results are shown in Table 1.
[實施例5] 實施例1中,除了將分散液之調配設為如下,除此之外以與實施例1同樣方法製造分散液。所得分散液設為「分散液2」。 成分 量 活性碳 9.0 (平均粒徑;35μm、平均細孔直徑;3.4nm) 聚乙烯吡咯烷酮 6.3 (黏度平均分子量;2.5萬) 氫氧化鈉 0.129 水 84.571 [Example 5] In Example 1, a dispersion liquid was produced in the same manner as in Example 1 except that the preparation of the dispersion liquid was as follows. The obtained dispersion liquid was designated as "dispersion liquid 2". Ingredients Quantity Activated carbon 9.0 (Average particle size: 35μm, average pore diameter: 3.4nm) Polyvinylpyrrolidone 6.3 (Viscosity average molecular weight; 25,000) Sodium hydroxide 0.129 Water 84.571
除了使用所得之分散液2,墨水化時之調配設為如下以外,以與實施例1相同方法製造墨水。 成分 量(份) 分散液2(固形分10%) 62.5 丙二醇 25.0 水 12.5 所得墨水之平均分散粒徑為290nm,黏度為6.1mPa·s,pH為8.9。又所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,以與實施例1同樣進行評價。其結果示於表1。 The ink was produced in the same manner as in Example 1 except that the obtained dispersion 2 was used and the preparation of the ink was as follows. Ingredients Quantity (portions) Dispersion 2 (solid content 10%) 62.5 Propylene Glycol 25.0 Water 12.5 The average dispersed particle size of the obtained ink was 290 nm, the viscosity was 6.1 mPa·s, and the pH was 8.9. The resulting ink is uniformly black in appearance. Furthermore, the above-mentioned ink was evaluated in the same manner as in Example 1. The results are shown in Table 1.
[實施例6] 實施例5中,除了將墨水化時之組成設為如下以外,同樣製造墨水。 成分 量(份) 分散液2(固形分10%) 62.5 丙二醇 20.0 乙醇 5.0 水 12.5 所得墨水之平均分散粒徑為270nm,黏度為5.7mPa·s,pH為8.7。又所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,以與實施例1同樣進行評價。其結果示於表1。 [Example 6] In Example 5, ink was produced in the same manner except that the composition when converted into ink was as follows. Ingredients Quantity (portions) Dispersion 2 (solid content 10%) 62.5 Propylene Glycol 20.0 Ethanol 5.0 Water 12.5 The average dispersed particle size of the obtained ink was 270 nm, the viscosity was 5.7 mPa·s, and the pH was 8.7. The resulting ink is uniformly black in appearance. Furthermore, the above-mentioned ink was evaluated in the same manner as in Example 1. The results are shown in Table 1.
[實施例8] 實施例1中,除了將分散液之調配設為如下,除此之外以與實施例1同樣方法製造分散液。所得分散液設為「分散液3」。 成分 量 活性碳 9.0 (平均粒徑;35μm、平均細孔直徑;3.4nm) 聚乙烯吡咯烷酮 6.3 (黏度平均分子量;4萬) 氫氧化鈉 0.129 水 84.571 [Example 8] In Example 1, a dispersion liquid was produced in the same manner as in Example 1 except that the preparation of the dispersion liquid was as follows. The obtained dispersion liquid was designated as "dispersion liquid 3". Ingredients Quantity Activated carbon 9.0 (Average particle size: 35μm, average pore diameter: 3.4nm) Polyvinylpyrrolidone 6.3 (Viscosity average molecular weight; 40,000) Sodium hydroxide 0.129 Water 84.571
除了使用所得之分散液3,墨水化時之調配設為如下以外,以與實施例1相同方法製造墨水。 成分 量(份) 分散液2(固形分10%) 62.5 丙二醇 25.0 水 12.5 所得墨水之平均分散粒徑為346nm,黏度為7.7mPa·s,pH為9.2。又所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,以與實施例1同樣進行評價。其結果示於表1。 The ink was produced in the same manner as in Example 1 except that the obtained dispersion 3 was used and the preparation of the ink was as follows. Ingredients Quantity (portions) Dispersion 2 (solid content 10%) 62.5 Propylene Glycol 25.0 Water 12.5 The average dispersed particle size of the obtained ink was 346 nm, the viscosity was 7.7 mPa·s, and the pH was 9.2. The resulting ink is uniformly black in appearance. Furthermore, the above-mentioned ink was evaluated in the same manner as in Example 1. The results are shown in Table 1.
[實施例9] 實施例5中,除了將墨水化時之組成設為如下以外,同樣製造墨水。 成分 量(份) 分散液2(固形分10%) 62.5 丙二醇 20.0 乙醇 5.0 聚乙烯吡咯烷酮 2.0 (黏度平均分子量;2.5萬) 水 10.5 所得墨水之平均分散粒徑為307nm,黏度為7.6mPa·s,pH為8.0。又所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,以與實施例1同樣進行評價。其結果示於表1。 [Example 9] In Example 5, ink was produced in the same manner except that the composition when converted into ink was as follows. Ingredients Quantity (portions) Dispersion 2 (solid content 10%) 62.5 Propylene Glycol 20.0 Ethanol 5.0 Polyvinylpyrrolidone 2.0 (Viscosity average molecular weight; 25,000) Water 10.5 The average dispersed particle size of the obtained ink was 307nm, the viscosity was 7.6mPa·s, and the pH was 8.0. The resulting ink is uniformly black in appearance. Furthermore, the above-mentioned ink was evaluated in the same manner as in Example 1. The results are shown in Table 1.
[比較例1] ・分散液之製造 調配以下所示之成分,在室溫以螺旋翼攪拌機攪拌1小時。 成分 量(份) 氧化鐵紅 10.0 聚乙烯吡咯烷酮 8.5 (黏度平均分子量:4萬) 碳酸鈉 0.1 水 81.4 [Comparative example 1] ・Manufacture of dispersion liquid Prepare the ingredients shown below and stir with a propeller mixer at room temperature for 1 hour. Ingredients Quantity (portion) Iron oxide red 10.0 Polyvinylpyrrolidone 8.5 (Viscosity average molecular weight: 40,000) Sodium carbonate 0.1 Water 81.4
其次,對於所得之混合物,將150g直徑0.7mm之玻璃珠放入塗料搖晃用鍋中進行振動3小時。 將該分散液中所含之粗大粒子予以去除處理,調整為全粒子之90%以上的分散粒徑為500nm以下,固形分濃度為10重量%,作為「分散液3」。 Next, 150 g of glass beads with a diameter of 0.7 mm were placed in a paint shaking pot for the obtained mixture and vibrated for 3 hours. The coarse particles contained in this dispersion were removed, and the dispersed particle diameter of more than 90% of the total particles was adjusted to 500 nm or less, and the solid content concentration was 10% by weight, which was designated as "dispersion 3".
・墨水化 其次,將以下調配以螺旋翼攪拌機在室溫攪拌30分鐘,獲得墨水。 成分 量(份) 分散液3(固形分10%) 50.0 丙二醇 10.0 水 30.0 所得墨水之平均分散粒徑為452nm,黏度為5.5mPa·s,pH為8.2。又所得墨水外觀上顯示均勻的黑色。進而,針對上述墨水與實施例1同樣進行試驗並評價。其結果示於表1。 ・Ink Secondly, stir the following mixture with a propeller mixer at room temperature for 30 minutes to obtain ink. Ingredients Quantity (portion) Dispersion 3 (solid content 10%) 50.0 Propylene Glycol 10.0 Water 30.0 The average dispersed particle size of the obtained ink was 452 nm, the viscosity was 5.5 mPa·s, and the pH was 8.2. The resulting ink appears uniformly black. Furthermore, the above-mentioned ink was tested and evaluated in the same manner as in Example 1. The results are shown in Table 1.
[比較例2] 比較例1中,除了將氧化鐵紅設為黑色氧化鐵以外,同樣製作墨水。所得墨水之平均分散粒徑為1130nm,黏度為5.4mPa·s,pH為9.1。且所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,與實施例1同樣進行試驗並評價。其結果示於表1。 [Comparative example 2] In Comparative Example 1, an ink was produced in the same manner except that the iron oxide red was black iron oxide. The average dispersed particle size of the obtained ink was 1130 nm, the viscosity was 5.4 mPa·s, and the pH was 9.1. And the obtained ink shows uniform black color in appearance. Furthermore, the above-mentioned ink was tested and evaluated in the same manner as in Example 1. The results are shown in Table 1.
[比較例3] 比較例1中,除了將氧化鐵紅設為水溶性黑色染料以外,同樣製作墨水。所得墨水之黏度為4.2mPa·s,pH為7.1。且所得墨水在外觀上顯示均勻黑色。進而,針對上述墨水,與實施例1同樣進行試驗並評價。其結果示於表1。 [Comparative example 3] In Comparative Example 1, an ink was produced in the same manner except that iron oxide red was used as a water-soluble black dye. The viscosity of the obtained ink was 4.2 mPa·s and the pH was 7.1. And the obtained ink shows uniform black color in appearance. Furthermore, the above-mentioned ink was tested and evaluated in the same manner as in Example 1. The results are shown in Table 1.
[性能評價試驗 對人體表皮之書寫] 接下來,為了確認更詳細性能,使用離心機將實施例5所得之墨水及實施例5所得之墨水進行分級,使用將經去除粗大粒子之墨水(稱為「實施例7」)如下般填充之筆,藉由下述(A)及(B)之方法進行對人體書寫時之性能評價試驗。 將實施例5所得之墨水填充於筆尖使用由聚胺基甲酸酯樹脂黏結PET樹脂纖維束所成之前端作為略半球狀之纖維束芯(直徑12mm)之棉絮式標記筆中,作為「筆a」。其次,將實施例5所得之墨水填充於纖維束芯的直徑為9mm以外,與筆a同樣填充於標記筆中,作為「筆b」。同樣地,除了填充實施例7所得之墨水替代實施例5所得之墨水以外,與筆a同樣的筆,作為「筆c」,除了填充實施例7所得之墨水替代實施例5所得之墨水以外,與筆b同樣的筆,作為「筆d」。 [Performance evaluation test on human epidermis writing] Next, in order to confirm more detailed performance, the ink obtained in Example 5 and the ink obtained in Example 5 were classified using a centrifuge, and the ink from which coarse particles were removed (referred to as "Example 7") was filled as follows. The pen is used to perform performance evaluation tests on human writing using the following methods (A) and (B). Fill the ink obtained in Example 5 into a cotton-wool-type marking pen with a fiber bundle core (diameter 12 mm) that is slightly hemispherical at the tip and is made of polyurethane resin bonded PET resin fiber bundles. The tip is used as a "pen" a". Next, the ink obtained in Example 5 was filled into the fiber bundle core to a diameter other than 9 mm, and was filled into a marker pen in the same manner as pen a, to obtain "pen b". Similarly, the same pen as pen a was used as "pen c", except that the ink obtained in Example 7 was filled instead of the ink obtained in Example 5, except that the ink obtained in Example 7 was filled instead of the ink obtained in Example 5. The same pen as pen b is called "pen d".
(試驗方法) (A)對口腔內之書寫試驗 使用上述筆a~d,藉以下方法於成年男性的口腔內之下述部位進行書寫,並評價各性能。 (1)牙齦:從上頜兩顆門牙附近到牙齦根部書寫長5cm左右之曲線 (2)頰黏膜:於右臉頰內側書寫3條長3cm左右的直線 (3)舌頭:於舌頭上面中央書寫3條長3cm左右的直線 上述書寫後,確認書寫部。又,書寫後5分鐘後,以用水沾濕的紗布擦過3次,確認擦除性。 (Test method) (A) Writing test in the oral cavity Use the above-mentioned pens a to d to write on the following parts of the oral cavity of adult men by the following method, and evaluate each performance. (1) Gums: Write a curve about 5cm long from the vicinity of the two upper front teeth to the root of the gums (2) Buccal mucosa: Write three straight lines about 3cm long on the inside of the right cheek (3) Tongue: Write three straight lines about 3cm long in the center of the tongue After writing the above, confirm the writing part. In addition, 5 minutes after writing, the paper was wiped three times with gauze moistened with water to confirm the erasability.
(B)對皮膚表面之書寫試驗 使用上述筆a~d,藉以下各方法於成年女性之左右手腕內側的皮膚表面進行書寫,並評價各性能。 (1)以書寫部乾燥之狀態,書寫長5cm左右的直線及數字 (2)於用水潤濕書寫部之狀態,書寫長5cm左右的直線及數字 上述書寫後,確認書寫部。又針對右手腕,於書寫後5分鐘後,將書寫部以自來水的流水沖洗1分鐘,確認掉色及滲開。針對左手腕,於書寫後5分鐘後,以用水沾濕之紗布擦過3次,確認擦除性。 (B) Writing test on skin surface Using the above-mentioned pens a to d, write on the skin surface of the inner left and right wrists of adult women using the following methods, and evaluate each performance. (1) With the writing part in a dry state, write straight lines and numbers about 5cm long (2) With the writing part moistened with water, write straight lines and numbers about 5cm long After writing the above, confirm the writing part. For the right wrist, after 5 minutes of writing, rinse the writing area with running water for 1 minute to confirm discoloration and bleeding. For the left wrist, 5 minutes after writing, wipe it with gauze moistened with water three times to confirm the erasability.
(試驗結果) (A)對口腔內之書寫試驗之結果 各書寫部如圖1~圖12所示。 使用任一筆於任一部位之書寫中,均獲下述良好結果。 ・書寫性、噴出性:對任何部位均無墨水噴出不良或堵塞等之難以書寫,而可不滑開地進行書寫。 ・固定性:於黏膜及唾液覆蓋之部位,墨水均可固定、不流動地持續留在書寫部位。 ・顯色性:可明確視認到書寫之部位。 ・耐水性、乾燥性:未發生因唾液引起的滲開或模糊,可清楚地視認到書寫之部位。 ・擦除性:無滲出或擴散而將墨水擦掉,亦無色素沉積等且無殘留痕跡。 (Test results) (A) Results of the intraoral writing test Each writing part is shown in Figures 1 to 12. Use any stroke in any part of writing and get the following good results. ・Writability and ejection properties: There is no ink ejection failure or clogging at any part, making it difficult to write, and writing can be done without slipping away. ・Fixation: In areas covered by mucous membranes and saliva, the ink can be fixed and remain in the writing area without flowing. ・Color rendering: The writing area can be clearly recognized. ・Water resistance and dryness: No bleeding or blurring caused by saliva occurs, and the writing part can be clearly seen. ・Eraseability: No bleeding or spreading to wipe off the ink, no pigmentation, etc., and no residual traces.
(B)對皮膚表面之書寫試驗之結果 各書寫部示於圖13、圖14。又圖13中,右邊書寫之數字為「107-12」的直線係由筆a書寫者,為「107-9」的直線係由筆b書寫者,為「109-12」的直線係由筆c書寫者,為「109-9」的直線係由筆d書寫者。又圖13中之數字係使用分別對應的筆進行書寫。又圖14中,書寫於數字左側的直線係書寫於濕潤狀態之皮膚上的直線。 使用任一筆書寫時,(1)、(2)之書寫均獲得以下良好結果。 ・書寫性、噴出性:直線書寫及數字書寫均無墨水噴出不良及堵塞等之不易書寫,可不會滑掉地進行書寫。 ・固定性:即使為濕潤之情況,墨水亦可固定且不流動而持續留在書寫部位。 ・顯色性:所書寫之部位可明確視認。 ・耐水性、乾燥性:即使以流水亦不會滲開或模糊,可清楚地視認所書寫之部位。 ・擦除性:無滲出或擴散而將墨水擦掉,亦無色素沉積等且無殘留痕跡。 (B) Results of writing test on skin surface Each writing part is shown in Fig. 13 and Fig. 14. In Figure 13, the number "107-12" on the right is written by pen a, the number "107-9" is written by pen b, and the number "109-12" is written by pen b. The person who writes c is the person who writes the straight line "109-9" with pen d. The numbers in Figure 13 are written using corresponding pens. In Figure 14, the straight line written on the left side of the number is the straight line written on the skin in a moist state. When writing with any stroke, the following good results were obtained for writing (1) and (2). ・Writability and ejection properties: Both linear writing and digital writing are not difficult to write due to poor ink ejection or clogging, and you can write without slipping. ・Fixation: Even if it is wet, the ink can be fixed and will not flow, and will continue to stay in the writing area. ・Color rendering: The written part can be clearly recognized. ・Water resistance and dryness: Even if it is exposed to running water, it will not bleed or become blurred, and the written part can be clearly recognized. ・Eraseability: No bleeding or spreading to wipe off the ink, no pigmentation, etc., and no residual traces.
[性能評價試驗 對大鼠之書寫] (試驗方法) 進而以上述筆a,以符合JIS/ISO標準(JIS T 0806-1/ISO 11137-1及JIS T 0806-2/ISO 11137-2)之以下條件進行γ射線照射處理時,使用該筆a於實驗用大鼠(雄性SD大鼠,體重292g-346g,「日本SLC公司製」)之下述部位按以下方法進行書寫,進行書寫性確認及書寫部之經時觀察。 ‧γ射線照射處理: 放射性核種:Co60 照射設施:日本照射服務股份有限公司 東海中心內 照射容器:箱(78×50×150cm) 照射裝置:(型式)JS10000HD,IR-199(製造源)MDS Nordion 設定目標吸收劑量:50kGy(實測值54.0kGy~67.6 kGy) 照射時間:26,000秒 ・書寫部位: 腹部皮膚、頭蓋骨、大腿肌肉、舌頭、頰黏膜 ・書寫方法: 針對腹部皮膚,在全身麻醉下剃掉腹部的毛,於外皮上書寫寬1cm,長2cm左右之橢圓。為了確認書寫位置,使用藍色顏料分散液(御國色素製,「SA Blue 5636」),於書寫部周圍實施點狀刺青。針對頭蓋骨、大腿肌肉,於全身麻醉下切開各部位,與腹部皮膚同樣地使用標記筆於各部位書寫寬1cm,長2cm左右之橢圓,針對大腿肌肉實施點狀刺青並縫合。針對舌頭、頰黏膜,於全身麻醉下打開,實施直徑5mm左右之圓及點狀刺青。又,作為比較例,使用填充有氯化琥珀膽鹼0.2%水溶液(本草製藥股份有限公司製,「HONZO」)作為墨水的手術筆(瑞穗股份有限公司製,「田島式標記筆(皮膚筆)」,(以下稱為「筆e」))進行書寫,比較顯色性。 ・經時觀察: 將經書寫之大鼠在25℃下飼養14天,如下般確認第7天、第14天之書寫部的狀態。針對腹部皮膚,於第7天確認外皮狀態後,由於墨水已消失,故在全身麻醉下切除外皮並確認朝內皮之沉積程度。針對頭蓋骨、大腿肌肉,係在全身麻醉下再次切開各部位,目視確認後縫合。針對舌頭及頰黏膜係在全身麻醉下打開並目視確認。 [Performance Evaluation Test Writing on Rats] (Test method) Furthermore, when performing gamma ray irradiation treatment with the above-mentioned pen a under the following conditions that comply with JIS/ISO standards (JIS T 0806-1/ISO 11137-1 and JIS T 0806-2/ISO 11137-2), use the pen a Experimental rats (male SD rats, body weight 292g-346g, "Nihon SLC Co., Ltd.") were used to write on the following parts in the following method, and the writing properties were confirmed and the writing parts were observed over time. ‧γ-ray irradiation treatment: Radioactive nuclide: Co60 Irradiation facility: Nippon Irradiation Services Co., Ltd., inside Tokai Center Irradiation container: box (78×50×150cm) Irradiation device: (Type) JS10000HD, IR-199 (Manufacturing source) MDS Nordion Set target absorbed dose: 50kGy (actual measured value 54.0kGy~67.6 kGy) Irradiation time: 26,000 seconds ・Writing parts: Abdominal skin, skull, thigh muscles, tongue, buccal mucosa ・Writing method: For the abdominal skin, shave the abdominal hair under general anesthesia, and write an ellipse about 1cm wide and 2cm long on the outer skin. In order to confirm the writing position, a blue pigment dispersion ("SA Blue 5636" manufactured by Ogoku Pigment Co., Ltd.) was used to tattoo dots around the writing area. For the skull and thigh muscles, incise each part under general anesthesia. Use a marker pen to write an ellipse about 1cm wide and 2cm long on each part in the same way as the abdominal skin. Dot-like tattoos are performed on the thigh muscles and sutured. The tongue and buccal mucosa are opened under general anesthesia, and circular and dot-shaped tattoos with a diameter of about 5mm are performed. Moreover, as a comparative example, a surgical pen (manufactured by Mizuho Co., Ltd., "Tajima-type marking pen (skin pen)") filled with a 0.2% aqueous solution of succinylcholine chloride (manufactured by Honcho Pharmaceutical Co., Ltd., "HONZO") as ink was used. ", (hereinafter referred to as "pen e")) to write and compare the color rendering properties. ・Observation over time: The written rats were raised at 25° C. for 14 days, and the state of the writing part on the 7th and 14th days was confirmed as follows. Regarding the abdominal skin, after confirming the status of the outer skin on the 7th day, since the ink had disappeared, the outer skin was removed under general anesthesia and the degree of deposition toward the endothelium was confirmed. Aiming at the skull and thigh muscles, each part was incised again under general anesthesia and sutured after visual confirmation. The tongue and buccal mucosa were opened and visually confirmed under general anesthesia.
(試驗結果) 各書寫部如圖15~圖20所示。又,圖15中,圖中之2個橢圓中,下方為利用筆a之書寫部,上方為利用筆e之書寫部,各周圍的點係使用藍色顏料分散液之位置確認的刺青。又,圖16中,圖中下方之橢圓係利用筆a之書寫部,上方橢圓係利用筆e之書寫部。圖17中,圖中左側係藉由筆a書寫的大腿肌肉,右側係利用筆e書寫之大腿肌肉。圖18中,亦於與圖15同樣之部位分別使用筆a、筆e進行書寫,但如下般兩者消失。利用筆a之書寫於對任一部位之書寫中,均獲得下述良好結果。 ・書寫性、噴出性:沒有墨水的噴出不良或堵塞等之不易書寫,而不會滑開可進行書寫。 ・固定性:即使被血等弄濕時,墨水仍可固定且不流動地持續留在書寫部位。 ・顯色性:於經書寫之部位可明確視認。可確認到與筆e相同以上之視認。(圖15、圖16、圖17) ・耐水性、乾燥性:不會因血、體液等而滲開,不發生模糊,經書寫之部位可清楚視認。 ・擦除性(經時確認):針對腹部皮膚,於經過7天之時點可確認外皮墨水消失(圖18),確認經書寫之外皮正下方的內皮,但未見到顏色沉積等(圖19)。針對大腿肌肉,於經過14天之時點,確認大部分墨水消失(圖20)。針對舌頭、頰黏膜則無法判別。針對頭蓋骨,於經過14天之時點確認殘存一部分墨水。 (Test results) Each writing part is shown in Figures 15 to 20. In addition, in Figure 15, among the two ovals in the figure, the lower part is the writing part using pen a, and the upper part is the writing part using pen e. The points around each are tattoos whose positions are confirmed using the blue pigment dispersion. In addition, in Figure 16, the lower ellipse in the figure is the writing part using pen a, and the upper ellipse is the writing part using pen e. In Figure 17, the left side of the figure shows the thigh muscles written with pen a, and the right side shows the thigh muscles written with pen e. In FIG. 18 , pen a and pen e are used to write on the same parts as in FIG. 15 , but they disappear as shown below. When writing with pen a, the following good results were obtained in writing on any part. ・Writability and ejection properties: There is no difficulty in writing due to poor ink ejection or clogging, and it does not slip open so you can write. ・Fixability: Even when it gets wet with blood, etc., the ink remains fixed and stays on the writing site without flowing. ・Color rendering: The part where the sutra is written can be clearly recognized. The same visual recognition as pen e can be confirmed. (Figure 15, Figure 16, Figure 17) ・Water resistance and dryness: It will not seep out due to blood, body fluids, etc., and will not be blurred. The written part can be clearly recognized. ・Eraseability (confirmed over time): Regarding the abdominal skin, it was confirmed that the outer skin ink disappeared after 7 days (Figure 18), and the endothelium directly under the outer skin was confirmed to be written, but no color deposition was seen (Figure 19 ). Regarding the thigh muscles, it was confirmed that most of the ink disappeared after 14 days (Figure 20). It is impossible to distinguish the tongue and buccal mucosa. For the skull, it was confirmed that some ink remained after 14 days.
[性能評價試驗 γ射線照射前後之物性比較/經時評價試驗] 其次,與實施例5、實施例6同樣再次製造墨水,將所得墨水分別作為實施例5-2、實施例6-2測定平均分散粒徑、黏度、pH。 隨後,將各墨水放入聚乙烯容器中,於與對大鼠之書寫試驗相同的設備、條件下進行γ射線照射處理,再次測定黏度、平均分散粒徑、pH。 又,為了確認長期保存中之物性有無變質,作為經時評價試驗,將γ射線處理前、處理後之墨水分別於25℃、50℃之恆溫室中保存,測定30天、60天、90天經過後之平均分散粒徑、黏度、pH。其結果示於表2。又表2中,所謂「變化率」係將照射前、照射後之各條件下之保存前(經過0天時點)之物性值設為100%,與該數值相比減少時以 -%表示,相比上升以+%表示者。 [Performance evaluation test: Comparison of physical properties before and after γ-ray irradiation/Time evaluation test] Next, ink was produced again in the same manner as in Example 5 and Example 6, and the average dispersed particle size, viscosity, and pH of the obtained ink were measured as Example 5-2 and Example 6-2, respectively. Subsequently, each ink was placed in a polyethylene container, irradiated with gamma rays under the same equipment and conditions as the writing test on rats, and the viscosity, average dispersed particle size, and pH were measured again. In addition, in order to confirm whether the physical properties have deteriorated during long-term storage, as a time-lapse evaluation test, the ink before and after gamma ray treatment was stored in a constant temperature room at 25°C and 50°C, respectively, and measured for 30 days, 60 days, and 90 days. The average dispersed particle size, viscosity and pH after processing. The results are shown in Table 2. In Table 2, the so-called "change rate" refers to the physical property value before storage (0 days after 0 days) under each condition before irradiation and after irradiation. When it decreases from this value, it is expressed as -%. The relative increase is expressed as +%.
[經時書寫試驗] 針對實施例5所得之墨水藉以下方法進行經時書寫試驗。首先,將實施例5所得之墨水填充到與上述(b)書寫性試驗所用者相同的標記筆中製造筆。製造複數個筆並平分為6組:A、B、C、D、E、F。將A、B及C組的筆放入25℃之恆溫室中,D、E及F組的筆放入50℃之恆溫室中,對每組按以下朝向靜置。 ‧A組及D組:朝上(筆尖朝天,筆相對於水平面垂直靜置) ‧B組及E組:朝下(筆尖朝地,筆相對於水平面垂直靜置) ‧C組及F組:橫向(使筆呈水平靜置) 靜置後30天、60天及90天後,使用各筆於普通紙上以書寫距離為60cm之方式手動書寫線。A~F之各組中,半數以直線書寫,其餘以曲線書寫。於直線之書寫中,以每10秒為15cm之速度書寫,於彎曲書寫中,以每10秒60cm之速度書寫。 針對所書寫的線,目視確認是否有模糊、色淡。模糊、色淡嚴重於實用上有問題者線的視認性降低者記為×,多少有模糊、色淡但視認性之降低於實用上不成問題者記為△,幾乎未確認到模糊、色淡之線可清楚地視認者記為○。 [Time writing test] The ink obtained in Example 5 was subjected to a time-lapse writing test by the following method. First, the ink obtained in Example 5 was filled into the same marking pen used in the above-mentioned (b) writing property test to produce a pen. Make multiple pens and divide them into 6 groups: A, B, C, D, E, F. Place the pens in groups A, B and C into a constant temperature room at 25°C, and the pens in groups D, E and F into a constant temperature room at 50°C. Place each group in the following orientation. ‧Group A and D: Upward (the pen tip is facing upward, and the pen is placed vertically relative to the horizontal plane) ‧Group B and E: facing down (the pen tip faces the ground, and the pen rests vertically relative to the horizontal plane) ‧Group C and F: horizontal (position the pen horizontally) After 30 days, 60 days and 90 days of resting, use each pen to manually write lines on plain paper with a writing distance of 60cm. In each group from A to F, half are written in straight lines and the rest are written in curved lines. In straight writing, write at a speed of 15cm every 10 seconds; in curved writing, write at a speed of 60cm every 10 seconds. Check visually whether the written lines are blurry or light in color. Blurry or light color is more serious than a practical problem and the visibility of the line is reduced is marked as Lines that can be clearly recognized are marked as ○.
與實施例5同樣,針對實施例8及實施例9亦進行經時書寫試驗。又針對實施例9,不進行靜置後經過90天時之確認。 各結果示於表3。 Similar to Example 5, a time-lapse writing test was also performed on Examples 8 and 9. Regarding Example 9, confirmation after 90 days of standing was not performed. Each result is shown in Table 3.
由以上實施例及比較例,及效果確認試驗之結果可知,使用碳材料作為色材且含有特定水溶性高分子之本發明之墨水,具有作為手術墨水之優異特性。From the above examples and comparative examples, as well as the results of the effect confirmation test, it can be seen that the ink of the present invention, which uses a carbon material as a color material and contains a specific water-soluble polymer, has excellent characteristics as a surgical ink.
此外,基於對實施例5所得之墨水之使用人體表皮及大鼠之性能評價試驗結果及作為圖1~圖20所示之書寫部的狀態,顯示於即使以血液、唾液、水等液體濕潤之活體中,本發明之墨水亦能良好地書寫,係書寫部可明確視認之優異手術墨水。又,於使用大鼠之性能評價試驗中,確認即使於γ射線照射處理後,亦可發揮作為手術墨水之優異性能,且基於外觀上之理由而於要求擦除性之皮膚表皮中具有良好的擦除性,與過去以來被作為手術墨水而廣泛使用之氯化琥珀膽鹼比較,亦確認到能展現毫不遜色之顯色性、書寫性。In addition, based on the performance evaluation test results of the ink obtained in Example 5 using human epidermis and rats, and the state of the writing part shown in Figures 1 to 20, it is shown that even if it is moistened with liquids such as blood, saliva, water, etc. The ink of the present invention can also write well in vivo, and is an excellent surgical ink whose writing part can be clearly recognized. In addition, in the performance evaluation test using rats, it was confirmed that even after gamma ray irradiation treatment, it can exhibit excellent performance as a surgical ink, and it has good performance on the skin epidermis where erasability is required for reasons of appearance. In terms of erasability, it has been confirmed that it exhibits color development and writing properties that are comparable to those of succinylcholine chloride, which has been widely used as surgical ink in the past.
進而,基於表2所示之γ射線照射前與照射後之物性比較,顯示即使於進行γ射線照射處理後,本發明之墨水仍維持作為手術墨水之適宜物性。 又,基於同樣如表2所示之經時評價之結果,確認實施例5-2之墨水無論是否用γ射線照射處理,於25℃之保存於經過90天後,均係平均分散粒徑、黏度、pH值都在前述最佳範圍內。又,於50℃之保存,亦確認於經過90天後之平均分散粒徑、黏度、pH都在前述較佳範圍內。 針對實施例6-2之墨水,確認到無論是否有γ射線照射處理,於25℃及50℃之保存兩者中,經過90天後之平均分散粒徑、黏度、pH亦均在前述最佳範圍內。 因此,即使填充於筆中長期保存時,本發明之墨水亦顯示可適當地使用作為手術墨水。 Furthermore, based on the comparison of the physical properties before and after γ-ray irradiation shown in Table 2, it is shown that the ink of the present invention maintains suitable physical properties as a surgical ink even after the γ-ray irradiation treatment. Furthermore, based on the results of the time-lapse evaluation also shown in Table 2, it was confirmed that the ink of Example 5-2 had an average dispersed particle diameter of The viscosity and pH value are both within the aforementioned optimal ranges. In addition, it was also confirmed that the average dispersed particle size, viscosity, and pH after 90 days of storage at 50°C were within the above-mentioned optimal ranges. Regarding the ink of Example 6-2, it was confirmed that regardless of whether it was irradiated with gamma rays or not, the average dispersed particle size, viscosity, and pH after 90 days of storage at 25°C and 50°C were all within the above-mentioned optimum. within the range. Therefore, even when filled in a pen and stored for a long period of time, the ink of the present invention has been shown to be suitably used as a surgical ink.
又,對於實施例5、實施例8及實施例9所得之墨水之經時書寫試驗中,即使將本發明之墨水填充於筆中長期保存時,顯示於25℃下保存時以任何朝向均可維持良好書寫性。又,針對自實施例5而黏度提高之實施例8及實施例9的墨水,以書寫性容易惡化之朝下之狀態,且於50℃保存時,顯示於長期間內可維持足以實用之書寫性。Furthermore, in the time-lapse writing test of the inks obtained in Examples 5, 8 and 9, even when the ink of the present invention was filled in a pen and stored for a long time, it was shown that the ink can be stored in any orientation at 25°C. Maintain good writing ability. In addition, when the inks of Examples 8 and 9, whose viscosity increased from Example 5, were stored at 50° C. in a face-down state in which the writing properties tended to deteriorate, it was shown that they could maintain practical writing capabilities for a long period of time. sex.
又,實施例1、2、3、4、6、8及9所得之墨水,於表1所示之評價結果與實施例5相同,且關於被認為對墨水之書寫性、固定性有很大影響的平均分散粒徑、黏度值與實施例5無顯著差異,且係同樣含有被推測對墨水之性能有較大助益之活性碳、聚乙烯吡咯烷酮之與實施例5類似之組成。因此,針對實施例1、2、3、4、8及9所得之墨水,對於人體表皮及大鼠之性能評價試驗以及γ射線照射前後之物性測定/經時評價試驗中,獲得與實施例5及實施例5-2所得之墨水同樣的良好結果,當然可預見適合用於手術用途。同樣,針對實施例6所得之墨水,對於人體表皮及大鼠之性能評價試驗中,亦獲得與實施例5所得之墨水同樣的良好結果,當然可預見適合用於手術用途。 [產業上之可利用性] In addition, the evaluation results shown in Table 1 for the inks obtained in Examples 1, 2, 3, 4, 6, 8 and 9 are the same as those in Example 5, and it is considered that the ink has a great influence on the writing properties and fixability of the ink. The affected average dispersed particle size and viscosity value are not significantly different from those in Example 5, and the composition is similar to that in Example 5, including activated carbon and polyvinylpyrrolidone, which are presumed to have a greater contribution to the performance of the ink. Therefore, for the inks obtained in Examples 1, 2, 3, 4, 8 and 9, in the performance evaluation test on human epidermis and rats and the physical property measurement/time evaluation test before and after gamma ray irradiation, the results obtained were the same as those in Example 5 With the same good results as the ink obtained in Example 5-2, it is certainly foreseeable that it will be suitable for surgical use. Similarly, in the performance evaluation test on human epidermis and rats, the ink obtained in Example 6 also obtained the same good results as the ink obtained in Example 5, and it is of course expected to be suitable for surgical use. [Industrial availability]
藉由本發明,可提供僅以體內可攝取之成分構成,滿足作為手術墨水所必要之要求特性,進而適合使用於以手術筆之書寫的優異墨水、使用其之書寫方法及手術標記筆用墨水之製造方法。且,亦可適用於對化妝品、衛生用品、食品、玩具、嬰幼兒日用品、醫藥品等之書寫、加飾、印刷等之各種目的可使用本發明之墨水。By the present invention, it is possible to provide an excellent ink that is composed only of ingredients that can be taken into the body, satisfies the required characteristics as a surgical ink, and is suitable for use in writing with a surgical pen, a writing method using the same, and an ink for a surgical marking pen. Manufacturing method. In addition, the ink of the present invention can be used for various purposes such as writing, decorating, and printing on cosmetics, sanitary products, food, toys, daily necessities for infants, and pharmaceuticals.
[圖1]係顯示實施例中使用筆a進行書寫之牙齦的圖。 [圖2]係顯示實施例中使用筆b進行書寫之牙齦的圖。 [圖3]係顯示實施例中使用筆c進行書寫之牙齦的圖。 [圖4]係顯示實施例中使用筆d進行書寫之牙齦的圖。 [圖5]係顯示實施例中使用筆a進行書寫之頰黏膜的圖。 [圖6]係顯示實施例中使用筆b進行書寫之頰黏膜的圖。 [圖7]係顯示實施例中使用筆c進行書寫之頰黏膜的圖。 [圖8]係顯示實施例中使用筆d進行書寫之頰黏膜的圖。 [圖9]係顯示實施例中使用筆a進行書寫之舌頭的圖。 [圖10]係顯示實施例中使用筆b進行書寫之舌頭的圖。 [圖11]係顯示實施例中使用筆c進行書寫之舌頭的圖。 [圖12]係顯示實施例中使用筆d進行書寫之舌頭的圖。 [圖13]係顯示實施例中進行書寫且乾燥之皮膚的圖。 [圖14]係顯示實施例中進行書寫且濡濕之皮膚的圖。 [圖15]係顯示實施例中使用筆a、筆e進行書寫之大鼠剛書寫後之腹部外皮的圖。 [圖16]係顯示實施例中使用筆a、筆e進行書寫之大鼠剛書寫後之頭蓋骨的圖。 [圖17]係顯示實施例中使用筆a、筆e進行書寫之大鼠剛書寫後之大腿肌肉的圖。 [圖18]係顯示實施例中使用筆a、筆e進行書寫之大鼠於經過7天後之腹部外皮的圖。 [圖19]係顯示實施例中使用筆a、筆e進行書寫之大鼠於經過7天後之腹部內皮的圖。 [圖20]係顯示實施例中使用筆a進行書寫之大鼠於經過14天後之大腿肌肉的圖。 [Fig. 1] is a diagram showing the gums for writing using the pen a in the embodiment. [Fig. 2] is a diagram showing the gums for writing using the pen b in the embodiment. [Fig. 3] is a diagram showing the gums for writing using the pen c in the embodiment. [Fig. 4] is a diagram showing the gums for writing using the pen d in the embodiment. [Fig. 5] is a diagram showing the buccal mucosa for writing using pen a in the Example. [Fig. 6] is a diagram showing the buccal mucosa for writing using the pen b in the Example. [Fig. 7] is a diagram showing the buccal mucosa for writing using the pen c in the Example. [Fig. 8] A diagram showing the buccal mucosa for writing using the pen d in the Example. [Fig. 9] is a diagram showing the tongue used for writing using the pen a in the embodiment. [Fig. 10] is a diagram showing the tongue used for writing using the pen b in the embodiment. [Fig. 11] is a diagram showing the tongue used for writing using the pen c in the embodiment. [Fig. 12] is a diagram showing the tongue used for writing using the pen d in the embodiment. [Fig. 13] Fig. 13 is a diagram showing skin that was written and dried in the Example. [Fig. 14] A diagram showing skin that was written on and moistened in Example. [Fig. 15] Fig. 15 is a diagram showing the abdominal skin of a rat immediately after writing using pen a and pen e in the Example. [Fig. 16] A diagram showing the skull of a rat just after writing using pen a and pen e in the Example. [Fig. 17] Figure 17 is a diagram showing the thigh muscles of a rat immediately after writing using pen a and pen e in the Example. [Fig. 18] Figure 18 is a diagram showing the abdominal skin of a rat after 7 days of writing using pen a and pen e in the Example. [Fig. 19] Figure 19 is a diagram showing the abdominal endothelium of rats after 7 days of writing using pens a and pen e in Examples. [Fig. 20] Figure 20 is a diagram showing the thigh muscles of the rat that used pen a to write in the Example after 14 days.
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022-023688 | 2022-02-18 | ||
JP2022023688 | 2022-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202348748A true TW202348748A (en) | 2023-12-16 |
Family
ID=87578716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW112105754A TW202348748A (en) | 2022-02-18 | 2023-02-17 | surgical marking ink |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN118715294A (en) |
TW (1) | TW202348748A (en) |
WO (1) | WO2023157954A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012126820A (en) * | 2010-12-15 | 2012-07-05 | Sakura Color Products Corp | Solid marking pen |
WO2013058810A1 (en) * | 2011-10-20 | 2013-04-25 | EndoChoice | Ink formulation and manufacture thereof |
JP6101666B2 (en) * | 2014-10-27 | 2017-03-22 | 紀州技研工業株式会社 | Ink jet ink and printing method thereof |
JP6530769B2 (en) * | 2015-01-21 | 2019-06-12 | クオリカプス株式会社 | Ink, method for producing edible body using the same, and printing method for edible body |
JP6960695B1 (en) * | 2020-05-27 | 2021-11-05 | 紀州技研工業株式会社 | Inkjet ink for tablets |
KR102350083B1 (en) * | 2020-07-10 | 2022-01-10 | 이상주 | Marker composition and laser irradiation method using thereof |
-
2023
- 2023-02-17 WO PCT/JP2023/005812 patent/WO2023157954A1/en unknown
- 2023-02-17 CN CN202380022126.6A patent/CN118715294A/en active Pending
- 2023-02-17 TW TW112105754A patent/TW202348748A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023157954A1 (en) | 2023-08-24 |
CN118715294A (en) | 2024-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3591013B1 (en) | Inkjet printing ink | |
JP6771138B2 (en) | Ink and method of manufacturing edible material using it and method of printing edible material | |
JP7329838B2 (en) | Hydrogel composition, biological tissue model, and method for producing biological tissue model | |
ES2841139T3 (en) | Aqueous ink composition for writing instruments | |
EP3650006A1 (en) | Cosmetic ink, inkjet printing ink containing same, ink cartridge, and cosmetic sheet and method for producing same | |
JP6960695B1 (en) | Inkjet ink for tablets | |
Granick et al. | Surgical skin-marking techniques | |
Gaihre et al. | Two-dimensional nanomaterials-added dynamism in 3D printing and bioprinting of biomedical platforms: Unique opportunities and challenges | |
Zare et al. | Hydrogel-integrated graphene superstructures for tissue engineering: from periodontal to neural regeneration | |
Wang et al. | Poly (vinyl alcohol)/graphene nanocomposite hydrogel scaffolds for control of cell adhesion | |
TW202348748A (en) | surgical marking ink | |
Damiri et al. | Nano-hydroxyapatite (nHAp) scaffolds for bone regeneration: Preparation, characterization and biological applications | |
US11767441B2 (en) | Cosmetic ink, ink jet ink and ink cartridge including the same, and method for producing cosmetic sheet | |
CN112126279A (en) | Color developing ink for surgical incision marking, preparation method thereof and marking pen using color developing ink | |
KR101753832B1 (en) | Hydrogel Alginate Non-woven mask pack | |
JP7091148B2 (en) | Water-soluble sheet-like coloring material | |
JP5037958B2 (en) | Water-based ballpoint pen ink composition | |
JP6883748B2 (en) | Inkjet printing ink | |
EP3889226B1 (en) | Peelable ink composition with color-changing for porous substrates | |
WO2023157953A1 (en) | Surgical ink, production method for said ink, and surgical pen using said ink | |
WO2024214776A1 (en) | Ink for skin marker and skin marker | |
JPH08143807A (en) | Water-base ink composition | |
JP5037815B2 (en) | Knock-type water-based ballpoint pen that can be discolored or discolored | |
CN109675068A (en) | A kind of medical ultrasonic coupling agent and preparation method thereof with sterilizing function | |
JP7186416B2 (en) | Water-based makeup cosmetics |